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1. Summary 
Rett Syndrome (RS) is a neurodevelopmental disorder caused primarily by mutations in a 
Mecp2 gene on the X chromosome that encodes methyl-cytosine binding protein (MeCP2). 
MeCP2 acts as a transcriptional repressor and an activator for a number of genes such as DLX5/ 
Dlx5 and Bdnf. One of the effects of diminished Mecp2 expression activity is the appearance of a 
Rett-like phenotype including tremors, severe breathing irregularities, and hypoactivity. Neurons 
of pre-Bötzinger complex (preBötC), the most important component of the complex respiratory 
network on which the generation of respiratory rhythm in mammals is relied were used to study 
possible origins of breathing disturbances. The research was focused on two major players of 
intracellular signal transduction, Ca
2+ 
and cAMP, involved in various events of neuronal activity 
and plasticity, to establish disturbances in signal transduction, excitability, and higher 
vulnerability of the Mecp2-/y (KO) preBötC neurons during early postnatal development. Using 
recently developed methods of transduction of living neural tissue with neuron-specific 
fluorescent sensors, D3cpv calcium sensor and exchange protein directly activated by cAMP 
(Epac1-camps) were introduced into the organotypic slices from wild-type (WT) and model 
knockout (KO) mice. Thereby differences in the spatial organisation of neurons in preBötC and 




]i) and cAMP ([cAMP]i) homeostasis in mutant mice 
which appeared in RS mouse model during early postnatal development were observed. 
Calcium buffering in KO neurons was indicated by increased amplitude and kinetics of 
depolarisation-induced calcium transients related to insufficient calcium uptake into the 
endoplasmic reticulum. Brief hypoxia and calcium release from internal stores induced global 
calcium increases, after which the processes of many KO neurons were retracted. The effects were 
restored after a treatment with BDNF while inhibition of BDNF signalling in WT neurons 
produced disturbances in calcium buffering similar to those observed in KO mice. The data 
obtained recently point to a direct connection between calcium homeostasis and long-term 
changes in neuronal connectivity. It can be therefore proposed that calcium-dependent retraction 
of neurites in preBötC neurons can retard the development of the neural network and set up 
conditions for appearance of breathing irregularities in RS. 
Transduction of organotypic slices with a sensor based on a cAMP-dependent GTP-
exchange factor (Epac1-camps) allowed us to measure the intracellular distribution of cAMP, its 
absolute levels and time-dependent changes in response to different physiological stimuli. After 
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modulation by adenylate cyclase (AC), inhibition of phosphodiesterase (PDE) and activation of 
G-protein-coupled metabotropic receptors, [cAMP]i changes in μM range were recorded. 
Membrane depolarisation and Ca
2+
 release from internal stores slowly increased [cAMP]i levels. 
These effects were suppressed after AC blockade with 2′5′-dideoxyadenosine, and potentiated 




89) in turn abolished these effects. This indicates the important role of phosphorylation of voltage-
sensitive Ca
2+
 channels in the potentiation of [cAMP]i transients. A crosstalk between Ca
2+
 and 
cAMP signalling that revealed a synergism of actions of these two second messengers was 
investigated. Resting [cAMP]i levels in KO neurons were lower and transient [cAMP]i changes 
were smaller and faster, but both features were corrected by BDNF to those of the WT. 
The results obtained indicate that KO neurons have significant disturbances in calcium and 
cAMP homeostasis that is possibly responsible for higher excitability and vulnerability of 
neurons. Calcium-induced retraction of neurites can retard formation of properly functioning 
respiratory network and produce instabilities in regular breathing. An important result that BDNF 
corrected both calcium and cAMP homeostasis corroborates the present view of the important role 
of MeCP2-regulated expression and secretion of BDNF in neuronal development. This supports 
the current opinion about the special role of BDNF in the development of RS that has been 





]i – cytoplasmic free Ca
2+
; 
[cAMP]i – intracellular concentration of cAMP; 
µOR – μ-opioid receptor; 
AAV – adeno-associated virus; 
AC – adenylate cyclase; 
ACSF – artificial cerebro-spinal fluid; 
AMPA – a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate; 
AP – action potential; 
ATP – adenosine triphosphate; 
BAPTA – 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid); 
Bdnf – gene encoding BDNF protein; 
BDNF – brain-derived neurotroohic factor; 
bGH – bovine growth hormone derived polyadenylation site; 
BrOMecAMP – 8-bromo-2'-OMe-cAMP; 
BSA – bovine serum albumin; 
CaM – calmodulin; 
CaMK – calmodulin dependent protein kinases; 
cAMP – cyclic adenosine monophosphate; 
CCCP – carbonyl cyanide m-chlorophenyl hydrazone; 
CCD – charge-coupled device; 






CNS – central nervous system; 





CREST – calcium-responsive transactivator; 
CSF – cerebrospinal fluid; 
DAG – diacylglycerol; 
DDA – 2′5′-dideoxyadenosine; 
DHPG – (S)-3,5-dihydroxyphenylglycine; 
DIV – days in vitro; 
D-MEM – Dulbecco/Vogt modified Eagle's minimal essential medium; 
DMSO – dimethyl sulfoxide; 
EDTA – ethylenediaminetetraacetic acid; 
EGFP – enchanced green fluorescent protein; 
EGTA – ethylene glycol tetraacetic acid; 
Epac – cAMP-dependent exchange factor; 
Epac1-camps – exchange protein directly activated by cAMP; 
ER – endoplasmic reticulum; 
FDA – The Food and Drug Administration goverment agency USA; 
Fig. – figure; 
FRET – fluorescence resonance energy transfer; 
GABA – gamma-aminobutiryc acid; 
GFP – green fluorescent protein; 




HDAC – histone deacetylases; 
HEK 293 – human embryonic kidney 293 cells; 
hSyn1 – short human synapsin-1 gene promoter 
IBMX – isobutylmethylxanthine; 
ICAN – Ca
2+
 -activated nonselective cationic current; 
IGF-1 – insulin-like growth factor 1 (IGF-1), somatomedin C; 
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INaP – persistent sodium current; 
Int – chimeric intron 
IO – inferior olive; 
IP(3)R – inositol thriphosphate receptor; 
IPSC – nhibitory postsynaptic current; 
ITR – inverted terminal repeats of AAV-2; 
K 252 – staurosporine aglycon; 
K-ATP channels – ATP-sensitive potassium channels; 
KO – Mecp2-/y (null) mice; 
L-NMMA – N-monomethyl-L-arginine; 
LED – light-emitting diode; 
LSM – laser scanning microscopy; 
MAPK – mitogen-activated kinase 
MBD – methyl-binding domain; 
MBD – methyl-CpG binding domain; 
mGluR1/5 – group I metabotropic glutamate receptor; 
Mecp2 – MeCP2 coding gene; 
MeCP2 – methyl-cytosine binding protein; 
NA – nucleus ambiguus  
NK1 – (TACR1, SPR) – neurokinin 1; 
NMDA – N-methyl-D-aspartate; 
NMRI – inbred line of mice for 51 generations, than transferred to the Naval Medical Research 
Institute; 
NOS – nitric oxide synthase; 
NTS – nucleus tractus solitarius; 
ODQ – 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one; 
P2R – purinergic receptor ; 
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P2Y – G protein-coupled purinergic receptors; 
P3-P49 – postnatal days 3-49; 
PBS – phosphate buffered saline; 
PDE – phosphodiesterase; 
PFA – phosphate buffered formaldehyde; 
pFRG – parafacial respiratory group; 
PIP2 – phosphatidylinositol 4,5-bisphosphate 
PLC – phospholipase C; 
PKA – protein kinase A; 
PKC – proteinkinase C; 
preBötC – pre-Bötzinger complex; 
PXX – postnatal day; 
RS – Rett Syndrome; 
RT – room temperature; 
RyR – ryanodine receptor; 
SERCA – Sarco/Endoplasmic Reticulum Ca
2+
-ATPase; 
SNAP – S-nitroso-N-acetylpenicillamine; 
SNpc – substantia nigra pars compacta; 
SPR – substance P receptor; 
SV40 – simian virus 40 derived polyadenylation site; 
TACR1 – tachykinin receptor 1; 
Tg – thapsigargin; 
TRD – transcription repression domain; 
TRH – thyrotropin-releasing hormone; 
TrkB – tyrosine kinase B; 
TRPM4 – calcium-activated nonselective cation channels; 
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UV – ultraviolet; 
VGCC – voltage-dependent calcium channel; 
VLM – ventrolateral medulla; 
VRC – ventral respiratory column; 
WPRE – woodchuck hepatitis virus posttranscriptional regulatory element; 
WT – wild-type; 
XII – nucleus hypoglossus; 
YFP – yellow flourescent protein. 
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3. Introduction 
3.1 Rett Syndrome 
Rett Syndrome (RS) is a neurodevelopmental disorder. It has been studied for more than 
50 years since 1954 when a Viennese physician Rett first noticed its symptoms in two girls who 
were making the same characteristic repetitive hand-washing movements (Rett, 1966). In 1983 
Hagberg and his colleagues finally raised the profile of RS and drew attention to this disorder 
(Hagberg et al., 1983). It was fairly soon discovered that the Rett Syndrome, named after its 
discoverer, affects primarily young females at the age of 6-18 months after an apparently normal 
period of growth and development, with an incidence of one per 10.000-15.000 by the age of 12 
years (Francke, 2006; Chahrour and Zoghbi, 2007). In 1999 it was discovered that RS is caused 
primarily by a genetic mutation in the gene that encodes MeCP2 - methyl-cytosine binding 
protein (Amir et al., 1999) and can arise sporadically or from germline mutations. This mutation 
was found in more than 95% of those meeting criteria for typical RS and more than 50% for 
atypical RS. The discovery of a monogenic origin of RS promoted it from a set of symptoms to 
the system disorder with a genetically defined origin and yet unknown development. 
MeCP2 is a member of the family of proteins capable of binding to methylated DNA and 
recruiting chromatin-modifying activities that causes the deacetylation and condensation of 
chromatin. As a result, MeCP2-binding regions in DNA become no more accessible to the 
transcription machinery and the corresponding genes cannot be expressed. Mecp2 mutation does 
not directly induce neurodegeneration but rather leads to the MeCP2-regulated changes in 
transcription patterns. These signalling moieties are required during the development that 
eventually leads to an RS-like phenotype including tremors, breathing irregularities and 
hypoactivity. The areas of the brain disrupted in RS are the frontal, motor, and temporal cortex, 
brainstem, basal forebrain, basal ganglia (which control many basic functions, such as 
movement), and they are critical for the normal development of the cortex or higher brain centre 
in late infancy. 
It is generally assumed that RS patients and Mecp2 null mice do not exhibit gross 
morphological abnormalities in brain organisation or detectable cell loss (Ogier and Katz, 2008). 
Reasonable reduction of brain size in RS is associated with marked reduction in dendritic 
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branching of pyramidal neurons in the frontal, temporal and motor cortices, and neurons in the 
subiculum (Armstrong, 2005), as well as shortening of dendritic spines in the frontal cortex 
(Belichenko et al., 1994). Neuronal size is reduced in the cortex, thalamus, basal ganglia, 
amygdala, and hippocampus (Kitt and Wilcox, 1995). Mecp2−/y mice also show a decreased 
cortical dendritic arborization (Kishi and Macklis, 2004), delayed neuronal maturation and 
synaptogenesis in the cerebral cortex (Fukuda et al., 2005), and reduction in synapse number in 
the hippocampus (Chao et al., 2007). Mutation in Mecp2 produces primarily changes in cellular 
organisation of the neural centres that control both movement and emotion (Budden et al., 2005), 
whereas their morphological appearance is not substantially changed (Ogier and Katz, 2008). 
Severity of RS can vary: since females have two X chromosomes, the normal version of 
the gene can compensate for much of the dysfunction. For males there is no compensation: males 
die young, within the first year of life (Schanen et al., 1998). In general, the disease is considered 
as embryonically lethal in males. There are still some ways to overcome this rule: genetic 
mosaicism is believed to be the reason for the survival of some individuals (Clayton-Smith et al., 
2000; Renieri et al., 2003), and a boy with 47,XXY karyotype has been described as well 
(Schwartzman et al., 1998). At present it is now known that MeCP2 can underlie various 
disorders which are not related to RS (Gonzales and LaSalle, 2010). Mecp2 mutations have been 
identified in children with schizophrenia (Shibayama et al., 2004) and some forms of autism 
(Beyer et al., 2002; Carney et al., 2003), as well as in those with severe mental retardation 
associated with movement disorders (Van Esch et al., 2005). Some women with very mild 
learning disabilities have also been found to carry Mecp2 mutations although in most cases 
mutations in Mecp2 led to the characteristic set of clinical signs (Wan et al., 1999). 
Clinically, the affected girls have a normal in utero development followed by a normal 
postnatal period extending up to 18 months. The symptoms appear at a stage when development 
slows down and gives way to stagnation and regression of previously acquired social skills and 
abilities to walk and to talk. Such patients have a severe mental retardation and demonstrate a 
language and motor mileston regress, a sudden arrest of brain development, and loss of 
purposeful hand use, followed by repetitive hand movements (clapping, tapping, wringing). Rett 
Syndrome Diagnostic Criteria Working Group (1988) reported that there were additional 
problems such as cognitive impairment and seizures, scoliosis, spasticity, breathing anomalies 
(for example Hagberg and colleagues (1883) identified hyperventilation, apnea, or sighing, and 
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epilepsy), abnormal blood circulation, and partial loss of verbal skills. Recent RS studies show 
that there are physiological dysfunctions that possibly underlie the clinical symptoms, such as 
EEG abnormalities, atypical brain glycolipids, elevated CSF levels of glutamate and beta-
endorphins, and reduction of substance P. The persons with Rett Syndrome symptoms that were 
recognized during their first 3 – 4 years may remain stabilized for interaction and cognitive 
function such as making choices for many decades. A final stage is characterized by reduced 
mobility so that even previously mobile patients lose their ability to walk. The life expectancy for 
patients with RS is around 50 years (Akbarian, 2002). 
3.2 MeCP2 
Almost 10 years after the discovery of the first mutations in Mecp2 causing RS and 16 years after the 
discovery of the gene itself in the mouse genome, the exact function of the MeCP2 protein is still unknown 
and remains the subject of many debates and many research projects! 
Medical Genetics & Functional Genomics Group, 
http://www.germaco.net/intro_rett_gb.html 
The Mecp2 gene controls production of MeCP2 protein which was first identified in mice 
in 1992 by the group of Adrian Bird (Lewis et al., 1992). The human gene was cloned in 1996 
(D‟Esposito et al., 1996). Now there are three different transcripts found in human (Pelka et al., 
2005) with still unclear differences in their function and distribution. MeCP2 is a member of the 
family of proteins able to bind to methylated DNA that represents an essential mechanism to 
repress transcription both in the heterochromatin and in regions which are transiently repressed. 
Methylation itself is not sufficient to repress the expression of a gene, but if additional proteins 
are recruited at these methylated sites the repression becomes possible (for a review, see Ulrey et 
al., 2004). MeCP2 has been initially shown to promote transcriptional repression through its 
binding of methyl-binding domain (MBD) to CpG dinucleotides and its subsequent recruitment 
by the transcription repression domain (TRD) of histone deacetylases (HDAC) that may modify 
the chromatin structure and make it inactive. However, MeCP2 protein is able to modify 
chromatin structure by histone deacetylase-independent mechanism of repression (Yu et al., 
2000) or without a need in methylated DNA (Georgel et al., 2003). Another way of transcription 
repression mediated by MeCP2 is a blockade of binding sites for transcription factors (di Fiore et 
al., 1999). 
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Although multiple mechanisms of regulation were revealed recently in searching of 
MeCP2 target proteins (for further details see Table 1), it is not possible to detect massive 
deregulation of gene transcription when the Mecp2 gene product is absent. MeCP2 proteins are 
able to regulate the promoter III of the brain-derived neurotrophic factor (Bdnf) gene, which is 
responsible for the production of a protein playing essential role both for the growth and survival 
of neurons (Martinowich et al., 2003; Chen et al., 2003). Bdnf repression by MeCP2 is a dynamic 
process: membrane depolarization leads to a dissociation of MeCP2 from a Bdnf promoter and 
hence to an increased Bdnf expression. This is accompanied by chromatin changes at this site 
(Nelson et al., 2006; Martinowich et al., 2003). 
Mecp2 gene is ubiquitously expressed. Although early developmental stages show the low 
levels of expression, Mecp2 is widely active in various types of embryonic and adult tissues and 
represented in different cell types. In the brain, it is found in high concentrations in the neurons 
and is associated with maturation of the central nervous system (CNS) being primarily involved 
in formation of synaptic contacts (LaSalle, 2007). A last year report (Ballas et al., 2009) showed 
that MeCP2 protein is also expressed in glial cells, where it was previously supposed to be 
absent. This raises an important issue whether glial cells in the mice lacking MeCP2 protein are 
responsible for neuronal defects. A large-scale mapping of MeCP2 binding sites in neurons 
demonstrated that only 6% of the binding sites are in CpG islands, 63% of MeCP2-bound 
promoters are actively expressed and only 6% are highly methylated (Lewis et al., 1992). This 
indicates that MeCP2 protein represents not only a global transcriptional regulator its main 
function is different from that of silencing methylated promoters. Modern studies demonstrate 
that MeCP2 acts not only as a transcriptional repressor but also as an activator for a number of 
genes through a recruitment of the transcription factor CREB1 (see Table 1). In fact, the majority 
of genes that are regulated by MeCP2 are rather activated than repressed (Chahrour et al., 2008). 
Recent studies (Guy et al., 2007) showed that neurological deficits resulting from a loss of 
MeCP2 can be reversed upon a restoration of gene function, indicating therefore a possibily of 
disease reversal. The neurons suffered from the loss of MeCP2 function can potentially regain 
functionality once MeCP2 is provided gradually and delivered at correct places. These findings 




Table 1. MeCP2 Target Genes (from Chahrour and Zoghbi, 2007) 
 
3.3 Mouse models of RS 
Mouse models (Guy et al., 2001) have set out a major breakthrough in the understanding 
of RS and MeCP2 function (Viemari et al., 2005; Nelson et al., 2006; Wang et al., 2006; Zhou et 
al., 2006; Chao et al., 2007; Stettner et al., 2007; Fischer et al., 2009). Observed similarities 
between RS in mice and in humans support a frequently encountered point of view (Gaultier and 
Gallego, 2008) that mutant newborn mice with targeted deletions of genes are a valuable research 
object for the development of new treatments for RS disorders in humans. Both in mice 
(Larimore et al., 2009) and humans (Wenk, 1997), post-mortem RS brains show a reduced 
overall size, a decrease in the size of individual neurons and a reduction of dendritic arborisation. 
At the same time there are some differences between the species discussed by Sun and Wu, 2006. 
In humans three different transcripts of Mecp2 (1.8; 7.5 and 10 kb) are present and their 
functional significance is yet unknown. In mice at least four different transcripts of Mecp2 have 
been shown to possess potential tissue-specific function in the regulation of MeCP2 protein 
synthesis at different ages (Pelka et al., 2005). This result makes the extrapolation of data 
obtained from different experimental models less obvious. 
Similar to human RS patients, homozygous female Mecp2 murine mutants are not viable 
whereas heterozygous females are phenotypically heterogeneous due to variable patterns of X-
MeCP2 Target Gene Function References 
Bdnf neuronal development and survival Chen et al., 2001; Martinowich et al., 2003 
xHairy2a neuronal repressor Stancheva et al., 2003 
DLX5/ Dlx5 neuronal transcription factor Horike et al., 2005 
Sgk1 hormone signaling Nuber et al., 2005 
Fkbp5  hormone signaling Nuber et al., 2005 
Uqcrc1 mitochondrial respiratory chain Kriaucionis et al., 2006 
ID1-3/ Id1-3 neuronal transcription factors Peddada et al., 2006 
FXYD1/ Fxyd1 ion channel regulator Deng et al., 2007 
IGFBP3/ Igfbp3 hormone signaling Itoh et al., 2007 
Crh neuropeptide McGill et al., 2006 
UBE3A ubiquitin ligase Samaco et al., 2008 
GABRB3 GABA-A receptor Samaco et al., 2008 
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chromosome inactivation. Therefore, the mayor part of research projects is focused on the effects 
of MeCP2 loss of function in hemizygous males (Mecp2−/y), which are completely devoid of 
MeCP2. As a result males tend to be more phenotypically homogenous than female 
heterozygotes (see Bissonnette and Knopp, 2006; Bissonnette and Knopp, 2008; Bissonnette et 
al., 2007). At least five RS mouse models have been created so far (Ogier and Katz, 2008) 
including 1) Mecp2−/y mice that has extended exonic deletion of the Mecp2 gene (Chen et al., 
2001; Guy et al., 2001; Pelka et al., 2006), 2) Mecp2
308
/y mice with truncation of MeCP2 protein 
at amino acid 308, a human RS mutation (Shahbazian et al., 2002), 3) Mecp
2Flox/y
 mice expressing 
a hypomorphic Mecp2 allele (Samaco et al., 2008), and 4) Mecp
2Tg1
 mice that overexpress 
MeCP2 protein (Luikenhuis et al., 2004). The data obtained from these models are presented on 
Table 2. In the third mouse model an N-terminal truncated form of MeCP2 is produced instead of 
the normal protein. These mice have a less severe phenotype with stereotypic forelimb 
movements, thus resembling a human phenotype more closely (Shahbazian et al., 2002). Human 
Mecp2 is mildly overexpressed in the forth model described by Luikenhuis et al. (2004). All 
these models mimic different degrees of severity of the human phenotype with large deletions of 
the protein leading to more serious forms of the disease. Yet not all the signs of RS clearly appear 
in each of them. Luikenhuis and colleagues (2004) showed that a Tau-Mecp2 transgene expressed 
exclusively in neurons could rescue the phenotype of Mecp2 mutant animals which means that 
the phenotypes of these models are indeed due to loss of function of MeCP2, particularly in 
neurons. Therefore the mouse models seem to be well suited to study the molecular mechanisms 
underlying the disease. 
3.4 RS and respiratory rhythmogenesis 
Breathing dysfunction in RS has complex pattern and is highly variable among affected 
individuals. It depends on the personal pattern of x-chromosome inactivation and on the level of 
behavioral arousal. In general, the RS breathing phenotype is characterized by forced and 
apneustic breathing, increased occurrence of apneas, and highly unstable breathing patterns 
including periods of breath-holds and hyperventilation and heterogeneous breath duration 
(Weese-Mayer et al., 2006). Mecp2−/y male mice develop breathing abnormalities similar to 
human RS; however, significant differences in respiratory phenotype exist among known strains 
(Ogier and Katz, 2008). The two main strains studied thus far, Mecp2
tm1.1Bird
 (Guy et al., 2001) 
and Mecp2
tm1.1Jae
 (Chen et al., 2001) both exhibit increased variability in breath duration and 
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 Table 2. Phenotypic features of the five mouse models established for RS (after Roloff 2005). 
Publication Genetic modification/Strains Phenotypis features 
Chen et al., 
2001  
CNS-specific deletion of exon 4 
















variability in breath duration and episodes of hyperventilation: 
hard breathing 
disordered breathing:  




mice, mean breathing frequency (and minute 
ventilation) is significantly increased in 5-week-old Mecp2
tm1.1Jae
 
null mice compared to wildtype controls by approximately 20%, 
similar to human RS patients (Weese-Mayer et al., 2006). 
At later stages: 
- overweight 
- physical deterioration 
- hypoactive 
- death at ~10 weeks 
- reduced brain size and weight 
Mecp2+/- females (normal for ~4 months): 
- weight gain  
- reduced activity 
- ataxic gait 
Guy et al., 
2001  














Mecp2 null mice (normal until ~3-8 weeks): 
- stiff, uncoordinated gate 
- hind limb clasping 




 null mice develop erratic breathing increased 
variability in the duration of the respiratory cycle alternating 
periods of fast and slow breathing frequencies  apneas (Viemari et 
al., 2005). Initial breathing disturbances worsen between the first 
and second months and the mice eventually die from fatal 
respiratory arrest (Viemari et al., 2005; Roux et al., 2007; Stettner 
et al., 2007; Zanella et al., 2008) 
 20 
apart from breathing they have: 
- uneven wearing of teeth 
- misalignment of jaws 
- rapid weight loss and death at ~54 days 
- reduced brain size and weight 
- males had internal testis 
- Mecp2+/- females: 
- inertia and hindlimb clasping after 3 months 
Shahbazian 
et al., 2002  
Remature stop codon at aa 308 








Mecp2308/y mice (normal until ~6 weeks): 
- first symptom is a subtle tremor when suspended by tail 
- tremor worsens with age 
- stereotypic forelimb motions and clasping when hung by tail 
- progressive motor dysfunction 
- decreased activity 
- kyphosis in 40% 
- fur oily and disheveled 
- spontaneous myoclonic jerks and seizures 
- normal brain size and weight 
Mecp2+/- females: 
- milder and variable phenotype 
Collins et 
al., 2004  
Slight over-exspression of 





- normal until ~10-12 weeks 






- premature death 
Samaco et 
al., 2008  
Mecp2
Flox/y
 mice expressing a 
hypomorphic Mecp2 allele with 
weaker phenotypic features 





- increased weight gain,  
- progressive motor impairments 
- altered social interaction.  
- increased respiratory variability and apneas 
- no change in the mean breathing frequency 
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episodes of hyperventilation (Viemari et al., 2005; Ogier et al., 2007; Zanella et al., 2008). 




 mice could result 
either from subtle differences in the exonic deletion between the two strains or due to the fact that 
these two mouse strains have different genetic background. For example, the fact that C57BL/6 
mice are particularly prone to spontaneous apneas from central origin (Stettner et al., 2008a; 
Stettner et al., 2008b) might explain why the apneic phenotype is more pronounced in 
Mecp2
tm1.1Bird
 mice, engineered on a pure C57BL/6 background, compared to Mecp2
tm1.1Jae
 null 
mice, engineered on a mixed C57BL/6, 129/sv, Balb/c background. 
Breathing abnormalities usually occur in mutant newborn mice deficient in genes 
involved in the development and modulation of rhythmogenesis of the respiratory network. Its 
most important element is pre-Bötzinger complex (preBötC) identified as a kernel of brainstem 
interneurons that are necessary and sufficient for generating inspiratory activity translated into a 
stable respiratory rhythm in mammals (Smith et al., 1991). The specific mechanisms that control 
rhythm generation are still subject to research; nevertheless it was established that preBötC 
includes glutamatergic network of rhythmic neurons (Bianchi et al., 1995; Ramirez et al., 1997) 
that is non-NMDA receptor-mediated (Thoby-Brisson and Greer, 2008). It was proposed that the 
neurons endow hyperpolarization-activated cationic channels (Rekling et al., 1996; Mironov et 
al., 2000; Thoby-Brisson et al., 2000) and the substance P receptor neurokinin 1 (NK1) (Gray et 
al., 1999; Wang et al., 2001; Stornetta et al., 2003; Pagliardini et al., 2003). In addition, it was 
proposed that preBötC neurons coexpress NK1R and μ-opioid receptor (µOR) (Gray et al., 1999) 
and show prominent tyrosine kinase B (TrkB) immunoreactivity which overlaps with the 
distribution of NK1R (Thoby-Brisson et al., 2003). Although most neurons in the preBötC may 
be not pacemakers (Del Negro et al., 2005), they can be recruited for rhythmic activity during 
inspiration, post-inspiration and expiration. NaP (Pena et al., 2004), CAN (Del Negro et al., 
2002), and TRPM4 (Mironov, 2008) channels were proposed for the initiators of „synaptic drive‟ 
promoting bursting activity. Synaptic inhibition also plays an important role in network function 
as it is active not only while a given neuron is „silent‟ (e. g., during expiration for an inspiratory 
neuron), but also during its active phases (Ramirez et al., 2005). Thus, the activity in a pacemaker 
cell in preBötC is determined by its intrinsic bursting properties and the concurrently occurring 
inhibitory and excitatory synaptic inputs, which both can be modulated through various 
neurotransmitters activating various intracellular signalling pathways. 
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Electrophysiological investigations of the RS-induced abnormalities in neuronal activity 
demonstrated that RS patients exhibit numerous manifestations of cortical hyperexcitability, 
including a higher incidence of seizures and appearance of rhythmic slow theta activity (Ramirez 
et al., 2005; Ogier and Katz, 2008). In MeCP2 deficient mouse models the imbalance between 
excitatory and inhibitory neurotransmission was reported (Dani et al., 2005; Moretti
 
et al., 2006). 
The effects were different depending on the brain region and mouse strain used for experiments. 
Spontaneous neuronal activity was reduced in adult cortical slices (Dani et al., 2005), as well as 
in a number of hippocampal excitatory glutamatergic synapses in vivo (Chao et al., 2007). Nelson 
and colleagues (2006) obtained similar results for spontaneous excitatory synaptic transmission 
in cell culture. Changes in synaptic plasticity and long-term potentiation in Mecp2 null 
hippocampal slices were shown by different research groups (Collins et al., 2004; Asaka et al., 
2006; Moretti et al., 2006). Note to say that Mecp2 null mice reported to have an 
excitatory/inhibitory imbalance in the mouse brainstem, including cell groups involved in 
regulation of breathing (Stettner et al., 2007). This suggests that the origin of the respiratory 
phenotype in Mecp2 null mice (and possibly RS patients) consists of generating breathing 
arrhythmias and increasing incidences of apneas. Moreover, laboratory results listed above allow 
one to associate upper airway-related problems in RS, including apneas with laryngeal closure 
and loss of speech (Budden et al., 1990), weak coordination of breathing and swallowing 
(Morton et al., 1997; Isaacs et al., 2003). 
3.5 Neurochemistry of the brainstem respiratory network in Mecp2 null 
mice 
The above considerations about the state of art of the problem of the generation and 
modulation of respiratory activity points to importance of the analysis of protein expression and 
functional differences of neurotransmitter systems in the Mecp2 null mice as a model organisms 
for RS research. The primary objects of interest were BDNF, biogenic amines (norepinephrine 
and serotonin), and the inhibitory transmitter gamma-amino butyric acid (GABA), which are all 




3.5.1 Biogenic amines 
Norepinephrine, dopamine, and serotonin levels in the Mecp2 null brain as a whole 
exhibit significant gradual decline after birth compared to wild type (WT) animals (Ide et al., 
2005). In the brainstem a postnatal deficit in norepinephrine is associated with a decrease in the 
number of neurons among cell groups expressing the catecholamine-synthesizing enzyme 
tyrosine hydroxylase (Viemari et al., 2005; Roux et al., 2007). These results give an impetus to 
pre-clinical and clinical studies of the efficacy of increasing noradrenergic signalling for 
improving respiratory function in RS which are currently in progress (Ogier and Katz, 2009). 
3.5.2 GABAergic signalling 
Spontaneous synaptic current carried by GABA(A) receptors are suppressed in rostral 
ventrolateral medullary neurons in Mecp2 null mice, but glycinergic signalling is not affected 
(Medrihan et al., 2008). Diminished GABAergic transmission correlates with decreased 
expression of both pre- and post-synaptic markers of GABA signalling indicating both decreased 
presynaptic levels of GABA and vesicular inhibitory amino acid transporter. 
3.5.3 Second messenger signalling. ATP. 
Respiration rhythm in mammals is persistently maintained to adjust continuously the 
concentration of vital gases in the blood. It is finely tuned to other movements such as 
swallowing, phonation and locomotion. On the neuronal level, the breathing is regulated through 
numerous neuromodulatory inputs to the respiratory network, e. g., preBötC, where the rhythmic 
motor output is produced. Various G-protein-coupled receptors (GPCR) are important in the slow 
modulation mechanisms which coordinate the rhythm generation. Muscarinic acetylcholine, 
tachykinin (substance P), serotonin, thyrotropin-releasing hormone (TRH), μ-opioid, α-
adrenergic, and GABAB receptors differentially modulate respiratory frequency and amplitude 
(Murakoshi et al., 1985), possibly mediating it via cell-to-cell communication in the respiratory 
network. Many preBötC neurons endow different types of GPCR as demonstrated by studies of 
single preBötC neurons in the respiratory network (Johnson et al., 1996; Rekling et al., 1996; 
Gray et al., 1999; Shao and Feldman, 2000). Downstream effectors of GPCRs often converge on 
cAMP-PKA pathway in neurons (Wojcik and Neff, 1984; Felder, 1995; Khawaja and Rogers, 
1996; Lukyanetz and Kostyuk, 1996; Oka et al., 1996; Nestler, 1997; Badie-Mahdavi et al., 2001; 
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Browning and Travagli, 2001; Cai et al., 2002). 
Although ATP is a ubiquitous cellular energy source, it participates in some signal 
transduction pathways by acting as an intercellular messenger molecule itself. It is claimed 
(Abbracchio et al., 2009) that purinergic receptors are the most abundant receptors in living 
organisms and their signalling role is important in both central and peripheral nervous system. 
Purinergic receptors are important in functioning of the autonomic nervous system at different 
levels. For example, ATP is involved in the autonomic reflex pathways ranging from the 
transduction of sensory information to neuroeffector transmission (Gourine et al., 2009). 
Purinergic receptors recognise ATP, ADP or adenosine produced due to activity-dependent release 
of ATP from nerve terminals, axons, and glia (Fields and Burnstock, 2006). 
Several studies performed in the last decade revealed multiple roles played by purinergic 
receptor (P2R) signalling in respiratory control. They are gated by extracellular ATP and 
subdivided into ionotropic (P2X1-7) and metabotropic (P2Y1,2,4,6,11-14) receptors (Mironov, 1995). 
At the periphery, P2X2Rs on the afferent terminals of the carotid sinus nerve in the carotid body 
are required for the hypoxic ventilatory response (Rong et al., 2003). P2Rs are expressed in spinal 
and brainstem respiratory motoneurons, where their activation by ATP potentiates output of 
respiratory motoneurons in vitro (Funk et al., 1997; Miles et al., 2002). P2XRs (Kanjhan et al., 
1999; Yao et al., 2000) and P2YRs (Fong et al., 2002) are also expressed throughout the 
ventrolateral medulla (VLM), including respiratory-related regions of the brainstem (Thomas et 
al., 1999; Spyer and Thomas, 2000; Thomas and Spyer, 2000; Thomas et al., 2001; Fong et al., 
2002; Lorier et al., 2007). Some inspiratory and expiratory neurons increase discharge frequencies 
in response to ATP (Gourine et al., 2003) and therefore were declared as uniquely sensitive to 
ATP, but further studies showed similar sensitivity to ATP for all classes of respiratory neurons. 
Lorier and colleagues (2008) concluded that P2Y1R-mediated frequency increase in activity 
seemingly reflects activation of a mixed cationic conductance in multiple types of preBötC 
neurone rather than excitation of one, highly sensitive group. 
Recent use of ATP biosensor technology demonstrated a physiological role of endogenous 
ATP and P2R signalling in central respiratory control. Gourine et al., (2005 a,b) showed that ATP 
is released in response to hypercapnia or hypoxia and that the resultant activation of P2Rs on cells 
near the ventral medullary surface or within the ventral respiratory column (VRC) contributes to 
the hypercapnic and hypoxic ventilatory responses (Lorier et al., 2008). 
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3.5.4 Second messenger signalling. Ca2+ 
Ca
2+
 is one of the most important intracellular messengers in many eukaryotic signal-
transduction pathways. Calcium complexes must be kept in low concentration to prevent cell 
damage. This is maintained by transport systems which mediate calcium extrusion from the 
cytoplasm or uptake into intracellular organelles. Nevertheless, in living cells Ca
2+
 interferes with 
many regulatory circuits which are especially important (Berg et al., 2002). For instance, in 
neurons changes in [Ca
2+
]i regulate different events from triggering of neurotransmitter release at 
presynaptic terminals to bursting activity. Ca
2+
 participates in rapid processes as well as in lasting 
for many days (Augustine et al., 2003). The characteristics of Ca
2+
 transients are shaped by Ca
2+
 
influx through voltage- and ligand-gated channels, intracellular release and endoplasmic 
reticulum (ER) buffering. Intrinsic Ca
2+
 buffering in preBötC neurons may be limited (Alheid et 
al., 2002), suggesting that Ca
2+ 
transients could play a particular role in generation of respiratory 




-dependent conductances to membrane 
potential variations in respiratory neurons has been studied both in vivo (Pierrefiche et al., 1995; 
Pierrefiche et al., 1999; Haji and Ohi, 2006) and in vitro (Onimaru et al., 1996; Elsen and 
Ramirez, 1998; Mironov and Richter, 1998). Optical imaging studies using cell permeat forms of 
Ca
2+
-sensitive dyes (e.g., fura-2 and fluo-3) reveal Ca
2+
 transients during inspiration both in 
active preBötC neurons (Frermann et al., 1999; Koshiya and Smith, 1999; Barnes et al., 2007; 
Funke et al., 2007; Mironov, 2008) and in respiratory-modulated motoneurons (Ladewig and 
Keller, 2000). 
In active preBötC neurons somatic Ca
2+
 transients occur during the inspiratory burst only 
as the consequence of action potentials (APs), while in the absence of APs the inspiratory drive 
potential was unaffected but somatic Ca
2+
 transients could not be detected (Morgado-Valle et al., 
2008), suggesting that such transients do not contribute to the inspiratory drive recorded in soma, 
the principal determinant for generation of APs. 
Imaging of somatic Ca
2+
 transients in phase with preBötC neuron inspiratory activity was 
used by many researches to study respiratory network connectivity, distribution, and 
development (Koshiya and Smith, 1999; Thoby-Brisson et al., 2005; Barnes et al., 2007; Funke et 
al., 2007). Ca
2+
 plays an essential role in termination of bursts of APs through activation of SK 
and BK K
+
 channels (Richter et al., 1993). This output is supported by an observation that 
inhibition of BK channels reduces inspiratory burst frequency (Zhao et al., 2006) and can 
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increase AP duration in preBötC neurons (Onimaru et al., 2003). Single neuron Ca
2+
 imaging 
established that high voltage-dependent calcium channels (VGCCs) are the dominant source of 
somatic Ca
2+
 in rhythmic respiratory neurons (Frermann et al., 1999). Somatic Ca
2+
 signals seen 
in active preBötC neurons are due to somatic APs induced by the inspiratory drive potential, and 
not by the inspiratory drive potential per se. Somatic [Ca
2+
]i was proved to arise due to a voltage-
dependent process rather than due to a process following activation of second messenger 
signalling cascades that release Ca
2+
 from intracellular stores much more slowly (Morgado-Valle 
et al., 2008). Activation of somatic TPRM4-like channels by Ca
2+
 was proposed as the 
mechanism generating the inspiratory drive (Mironov, 2008). In active preBötC inspiratory 
neurons, somatic Ca
2+
 transients do not significantly contribute to the inspiratory drive. It was 
proposed that dendritic Ca
2+
 transients in preBötC neurons play critical role in determining their 
excitability and ultimately their contribution to rhythm generation (Mironov, 2008; Morgado-
Valle et al., 2008). 
Intracellular PKA, PKC, cAMP, and Ca
2+ 
signalling pathways have functional 
significance in modulating the behavior of medullary respiratory neurons. Persistent activation of 
these pathways produces significant increases of excitability in medulary respiratory neurons. 
Neuromodulators including 5-HT, catecholamines, acetylcholine, adenosine, and opioids also act 
on the PKA, PKC and Ca
2+ 
signal pathways to alter synaptic processes and current flow through 
voltage- and ligand-gated membrane channels (Champagnat et al., 1979; Pierrefiche et al., 1993; 
Bonham, 1995). Such receptor-mediated regulation of intracellular signal pathways may stabilize 
the respiratory rhythm and produce functional flexibility that is advantageous for fine tuning of 
depth, frequency, and pattern of breathing (Richter et al., 1997). 
3.5.5 Second messenger signalling. cAMP and PKA 
ATP is used as metabolite in many signal transduction processes by various kinases in 
phosphate transfer reactions and by adenylate cyclase (AC) to produce the second messenger 
molecule cyclic AMP (Alberts et al., 2002). cAMP-dependent pathway is often initiated by 
activation of GPCRs. Increases in cAMP lead to activation of cyclic-nucleotide-gated ion 
channels, exchange proteins (Epacs) or cAMP-dependent protein kinase A (PKA). PKA 
participates in different cellular processes through phosphorylation of cellular proteins such as 
ion channels and receptors that modulates neuronal excitability and excitatory synaptic 
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transmission through the phosphorylation of glutamate receptors (Greengard et al., 1991; Wang 
et al., 1991; Wang et al., 1993; Blackstone et al., 1994; Colwell and Levine, 1995; Roche et al., 
1996; Traynelis and Wahl, 1997; Banke et al., 2000). For example, PKA potentiates the current 
induced by activation of AMPA glutamate receptors in hippocampal neurons (Greengard et al., 
1991; Wang et al., 1991) via increasing the opening frequency and the mean open time of AMPA 
glutamate receptors (Greengard et al., 1991). This possibly occurs through PKA-mediated 
phosphorylation of one subunit of the pentameric AMPA receptor (Roche et al., 1996) that 
increases peak open probability of AMPA receptors (Banke et al., 2000). The PKA modulation of 
postsynaptic AMPA receptors plays a role in synaptic plasticity by modulating synaptic strength 
and has significant implications for network behavior in many brain structures including 
hippocampus, the neostriatum, and the cerebral cortex (Blackstone et al., 1994; Colwell and 
Levine, 1995; Kameyama et al., 1998; Lee et al., 2000; Soderling and Derkach, 2000). 
PKA suppresses voltage- and calcium-gated K
+
 channels that regulate duration of action 
potentials and afterhyperpolarizations, as well as GABAB receptor-gated potassium channels 
(Laurenza et al., 1989; North and Uchimura, 1989; Greengard et al., 1991; Schwartz et al., 1991; 
Swope et al., 1992). In the expiratory neurons these effects control persistent and synaptically-
controlled K
+
 outward currents and depolarizing inward cation currents (Haji et al., 1996; Lalley 
et al., 1997).  
Enhancement of PKA activity in the preBötC increases the frequency of respiratory-
related rhythmic motor output, while inhibition of PKA activity decreases the frequency. PKA 
activation induces a tonic inward current, increases the endogenous inspiratory drive currents, as 
well as the exogenous AMPA-induced currents (Shao et al., 2003). On the other hand, 
modulation of AMPA receptors or associated synaptic proteins through inhibition of phosphatase, 
which counteracts with the effects of PKA, increases respiratory frequency, as well as the 
excitability of individual respiratory-related neurons (Ge and Feldman, 1998). AMPA receptors 
are critically involved in rhythm generation (Funk et al., 1993) and it has been observed that 
enhancement of PKA activity potentiates the AMPA-induced current in preBötC inspiratory 
neurons. One can conclude that the modulatory effects of PKA on respiratory rhythm are 
primarily due to phosphorylation of AMPA receptors or related synaptic proteins mediating 
excitatory synaptic transmission (Shao et al., 2003).  Another proteinkinase C (PKC) depends on 
both intracellular calcium and diacylglycerol formed after activation of metabotropic 
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neurotransmitter receptors via phosholipase C (PLC), additionally enhances GABA-mediated 
inhibitory postsynaptic currents whithin respiratory neurons (Richter, 1996). 
3.5.6 BDNF 
BDNF is a member of the neurotrophin family of growth factors known to be involved 
both in long-term processes of neuronal surviving (Levi-Montalcini, 1987; Davies, 1994; Lewin 
and Barde, 1996) and long-time potentiation (Korte et al., 1995; Patterson et al., 1996). It also 
participates in rapid events of ion channel activity, neurotransmitter release, and axon pathfinding 
(Song and Poo, 1999; Schinder and Poo, 2000; Kovalchuk et al., 2004). BDNF influences the 
expression of voltage-dependent conductances in both cell lines and neurons (Gonzalez and 
Collins 1997; Lesser et al., 1997; Oyelese et al., 1997; Sherwood et al., 1997) and modifies the 
intrinsic excitability of cortical neurons (Desai et al., 1999). In addition to its action as a neuronal 
survival factor, BDNF modulates synaptic function in newborn and adult animals in nucleus 
tractus solitarius (NTS) (Balkowiec et al., 2000), preBötC complex (Thoby-Brisson et al., 2003), 
Kölliker-Fuse nucleus (Kron et al., 2007a; Kron et al., 2007b) and spinal phrenic motoneurons 
(Baker-Herman et al., 2004), regulates synaptic plasticity (Bramham and Messaoudi, 2005; 
Turrigiano, 2007) and neuronal membrane conductances (Blum et al., 2002). 
It has been long known that the respiratory rhythm development is severely disrupted in 
mice carrying a targeted deletion in the gene encoding BDNF (Erickson et al., 1996; Balkowiec 
and Katz, 1998). Recent experimental studies  implicate an involvement of Bdnf, one of the 
identified transcriptional targets of MeCP2 (Chen et al., 2003; Martinowich et al., 2003), in the 
development of RS both in mice (Chen et al., 2003; Zhou et al., 2006; Ogier et al., 2007; 
Larimore et al., 2009) and in humans (Francke, 2006; Nectoux et al., 2008). Many of its actions 
are mediated by tyrosine kinase B receptors (Martinowich et al., 2003) which are proved to be 
expressed in preBötC (Thoby-Brisson et al., 2003). BDNF regulates respiratory rhythmogenesis 
by modulating activity of rhythmically active neurons in the preBötC (Thoby-Brisson et al., 
2003), expressing TrkB receptors important in the generation of the respiratory rhythm (Bouvier 
et al., 2008). Neurons in Mecp2 null mice showing clear signs of breathing irregularities express 
significantly lower levels of BDNF (Ogier et al., 2007) that may contribute to suppressed 
synaptogenesis (Zoghbi, 2003). 
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3.6 Transcription and neuronal activity 
Brain development is modified by the environment through a release of neurotransmitters 
at specific synapses and their binding to appropriate receptors on the postsynaptic neuron. This 
binding induces a variety of biochemical signalling events among which is a rapid and local 
increase in calcium levels within the postsynaptic specialization. Depending on the cellular 
context, it results in a number of synapse-specific alterations: a modification of glutamate 
receptor subunits, an alteration of the synaptic protein function via posttranslational 
modifications, and a stimulation of the translation or degradation of proteins at the synapse. 
Together, these events lead to changes in the synaptic function (reviewed in Catterall and Few, 
2008; Higley and Sabatini, 2008; and Wayman et al., 2008). Calcium influx into the postsynaptic 
neuron initiates local changes as well as a cascade of signalling events leading to the activation of 
a program of gene expression in nucleus that promotes dendritic growth, synapse development, 
and neuronal plasticity (Greer and Greenberg, 2008). 
Numerous researchers showed that there are several hundred genes regulated by neuronal 
activity when synapses are forming and maturing (Nedivi et al., 1993; Altar et al., 2004; Hong et 
al., 2004; Li et al., 2004; and Park et al., 2006). Many of these activity-regulated genes encode 
transcription factors that mediate the cellular response to synaptic stimulation. They are believed 
to activate target genes important for cell survival, shaping, synaptic development, and synaptic 
plasticity. Many of them are regulated directly by neuronal activity encode proteins that act 
specifically on synapses to control various aspects of the synaptic development and function. 
These include Bdnf that participates in neuronal surviving; Arc that controls glutamate receptor 
endocytosis; Cpg15 that regulates survival and dendritic growth; and Homer1a, which controls 
the formation of synaptic protein complexes (Kang and Schuman, 1995; Korte et al., 1995; 
McAllister et al., 1995; McAllister et al., 1997; Nedivi et al., 1998; Cantallops et al., 2000; Sala 
et al., 2003; Chowdhury et al., 2006; Rial Verde et al., 2006). 
Neurons, being excitable cells, maintain low basal levels of intracellular calcium by 
pumping calcium into either ER or extracellular space. Therefore a neuron is able to respond 
rapidly and effectively to an increase in intracellular calcium concentration in multiple ways. 
Cytoplasmic calcium levels can rapidly increase in the postsynaptic neuron either by a calcium 
release from ER, or by an entrance of extracellular Ca
2+
 into the cytoplasm through voltage-gated 
calcium channels or ligand-gated ion channels. As it was shown by Jonas and Burnashev (1995) 
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and Berridge (1998), two types of the ligand-gated ion channels participate in this process: the 
NMDA or AMPA glutamate receptors. Depending on the mode of entry, quite different 
responses in terms of gene induction can be observed (Bading et al., 1993) although all of them 
lead to the significant increases in the calcium concentration. For instance, BDNF is highly 
induced in excitatory neurons after calcium entry through L-type voltage-sensitive calcium 
channels, but the response to the calcium influx through NMDA receptors or N-type calcium 
channels is less effective (Westenbroek et al., 1992; Ghosh et al., 1994). This variability initially 
led to speculation that the specific channel through which calcium enters the neuron determines 
the pattern of gene induction. Recent studies demonstrated that triggering a gene expression 
response by the calcium influx depends on a variety of features of calcium channels. The channel 
conductance, open time, localization of the channel, ability to trigger an increase in the calcium 
concentration within the nucleus, and association with key signalling molecules – all these 
channel properties are essential for the trigger definition. Calcium influx through NMDA or 
AMPA receptors or L-type VSCCs triggers the expression of new gene products via a number of 
signalling molecules and pathways. The later in turn modify the activity of transcription factors 
and, hence, the transcription of several hundred genes. The pathways that respond to calcium 
influx via signalling cascades induced by calcium influx include the Ras/ mitogen-activated 
kinase (MAPK) pathway, calcium/calmodulin-dependent protein kinases, phosphatase 
calcineurin, and Rac GTPases. The mechanism of biological processes affected by calcium-
responsive genes on example of Bdnf regulation is described in Fig.1. Over 300 genes were 
shown to be regulated in response to neuronal activity, and each of them has a unique time course 
and magnitude of induction (Lin et al., 2008). Bdnf is one of the two genes precisely examined 
for such behaviour. Its transcription was preferentially activated in response to neuronal activity 
and hence was induced primarily in neurons (West et al., 2001). The proper balance of excitatory 
and inhibitory synaptic input is important for processing sensory information as well as for higher 
cognitive functions. An increasing number of human neurological disorders are characterized by 
imbalances in excitatory and inhibitory synaptic strength. Although, as was postulated by Cline 
(2005), the mechanism by which neuronal activity regulates inhibitory synapse development and 
maturation is still unknown (Cline, 2005), some researchers postulated that development and/or 
maintenance of inhibitory synapses was controlled by the activity-dependent gene network. 




Figure 1. Signaling Pathways that Lead to Calcium-Mediated Transcription of BDNF (modified 
from Zieg et al., 2008) 
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strength of excitatory synaptic connections (Dani et al., 2005). Cortical pyramidal neurons from 
Mecp2 knockout (KO) mice had reduced spontaneous synaptic activity. The data obtained from 
these mice allow one to assume that the alteration in excitability in Mecp2 KO mice is due to a 
change in the balance of excitatory and inhibitory synaptic strength. The effects of NPAS4, 
MEF2, and MeCP2 on the balance between excitation and inhibition are partially explained by 
their ability to regulate Bdnf promoter IV transcription. A study performed by Hong and 
colleagues (2008) supports the idea that activity-dependent transcription of Bdnf controls 
excitatory/inhibitory balance. Mice with modification in Bdnf promoter IV transcription have 
similar levels of BDNF in the absence of stimulation and reduced levels of Bdnf promoter IV-
dependent mRNA transcripts following synaptic stimulation. Notably, in these KO mice 
significantly afew inhibitory synapses form on excitatory neurons, so one can suggest that 
activity-dependent Bdnf transcription plays a key role in regulating the number of inhibitory 
synapses (Linn at al., 2008). 
During early postnatal development activity-dependent genes are highly induced and 
experience-dependent synaptic remodelling is peaking. This is the time when many disorders of 
human cognition appear. The possibility that defects in the Ca
2+
-dependent gene program are 
responsible for some disorders of human cognition is therefore postulated. This assumption is 
supported also by the evidence that mutations in a large number of the components of the 
activity-dependent gene program give rise to disorders of human cognition (Fig. 2). 
 Mutation in a number of molecules that regulate Bdnf transcription results in a variety of 
human cognitive disorders. Mutation in Cav1.2 transcription mechanism causes Timothy 
Syndrome, in RSK2 - Coffin-Lowry syndrome, in CBP - Rubenstein-Taybi Syndrome, in Bdnf 
itself - memory disturbances and psychiatric disorders, and finally mutation of Mecp2, an 
activity-regulated repressor of Bdnf promoter IV transcription, results in Rett Syndrome. All 
these mutations lead to disorders, including autism, and are first detected within first days and 
months of life following apparently normal early development. These symptoms arise during the 
period of development that is characterised by activity-dependent transcription during synaptic 
development (Zoghbi, 2003). Such coincidence of events raises the possibility that Rett 
Syndrome is a result of disturbances in activity-dependent gene transcription that depends on 
intracellular cascades (Greer and Greenberg, 2008). 
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Figure 2. Mutation of components of the activity-dependent Bdnf expression program lead to 
human cognitive disorders (adopted from Greer and Greenberg, 2008) 
 
As it is seen from the extended review presented above different approaches were intended lately 
to solve complex problem of Rett syndrome development. Mecp2 structure and functions were 
investigated on different levels of complexity. By now some of these aspects are pretty well 
revealed. Nevertheless there is not much known about processes lying in the gap between 
molecular composition of MeCP2 protein and changes in brain morphology as a complex 
network, caused by mutation in Mecp2 gene. 
This situation stimulates us to focus on physiological processes that underlie Rett syndrome 
development in respiratory neurons of pre-Bötzinger. In this work we are interested in getting 
more insight in the possible mechanism that lead to higher vulnerability of the Mecp2-/y (KO) 
preBötC neurons during early postnatal development. Based on the recently obtained results 
presented in the papers observed above we have chosen for further research two major players of 
intracellular signal transduction, Ca
2+ 
and cAMP, both involved in various events of neuronal 
activity, signal transduction, excitability and plasticity. 









4.1 Ethical approval 
All animals were housed, cared for and euthanized in accordance with the recom-
mendations of the European Commission (No. L358, ISSN 0378-6978), and protocols approved 
by the Committee for Animal Research, Göttingen University. 
4.2 Mouse strains 
Experiments were performed using the Mecp2 null mice as a model for RS. Two lines 
were maintained on a C57BL/6J background. The Mecp2 null mouse strain B6.129P2(C)-
Mecp2
tm1-1Bird 
(Guy et al., 2001) was obtained from the Jackson Laboratory (Bar Harbor, ME, 
USA). B6.129P2(C)-Mecp2
tm1-1Bird
 mice with deleted Mecp2 exons 3 and 4 are known to have 
normal development until 3-8 weeks. After approximately one month first signs of RS symptoms 
appear. Initial breathing disturbances became worse between the first and second months and the 
mice eventually die from fatal respiratory arrest (Viemari et al., 2005). All mice were genotyped 
in accordance with the Jackson Laboratory genotyping protocols described by Stettner and 
colleagues (2007). Studies were carried on hemizygous males because individual differences in 
X-inactivation pattern among heterozygous mice can result in variability in phenotype. 
Hemizygous mutant Mecp2−/y males (denoted hereafter as KO mice) were generated whereas 
MNRI males were crossed with heterozygous Mecp2 +/− females. The mice were examined 
blind and the data were then assorted into the two pools - the knock-outs and wild type (WT) – 
determined by their genotype. 
4.3 Cell culture 
Experiments were performed on neuronal cultures of brain stem containing functional 
respiratory network of mice. Preparations were made at postnatal day P3-P5. Animals were 
decapitated at the C3-C4 spinal level, the brain was isolated and placed in ice-cold artificial 
cerebrospinal fluid (ACSF) saturated with 95% O2, 5% CO2. ACSF contained 128 mM NaCl, 25 
mM NaHCO3, 1 mM NaH2PO4, 3 mM KCl, 1 mM MgSO4, 10 mM glucose, and 1.5 mM CaCl2. 
The brainstem was fixed by acrylic glue and sliced serially with a vibrotome from rostral to 
caudal direction until the beginning of preBötC was reached. The rostral boundary of the pre-
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Bötzinger complex is indicated by anatomical marks such as the inferior olive (IO), nucleus 
tractus solitarii (NTS), hypoglossal nucleus (XII), and nucleus ambiguus (NA) and by 
disappearance of the facial nucleus (Ruangkittisakul et al., 2006) as presented in Fig. 3. For 
isolation of preBötC neurons, a single thick transverse slice (650-750 μm) was cut and preBötC 
region was isolated by sucking into a large (ca. 1 mm inner diameter) bore fire-polished glass 
pipette. The piece of tissue was dispersed and trypsinised (1% trypsin, 0.25% EDTA, 5-10 min). 
The cell suspension was placed on poly-D-lysine-coated 18 mm glass coverslips in the D-MEM 
solution contained 85% of D-MEM (GIBCO, INVITROGEN), horse serum, 1% of 
Penicillin/Streptomycin, 15 mM of KCl, 1 mM of Na-pyruvate and 2 mM of L-glutamine. After 
the cells settled down in 4-well plates containing coverslips, the preparation was placed in the 
CO2-incubator. Next day the medium was changed to Neurobasal-A medium (GIBCO, 
INVITROGEN), with B-27 supplement, L-glutamine, and Penicillin/Streptomycin and every 
second day afterwards. 
Experiments were usually performed from 5 to 10 days in vitro (DIV). Coverslips with 
cultured neurons were mounted in the experimental chamber on a microscope table and the 
neurons were continuously perfused with warm ACSF. 
Data were collected only from viable cells, i.e., from cells showing intracellular calcium 
increases in Fluo-3 or Fura-2-stained after short challenges to membrane depolarisations elicited 




). The time of solution exchange was less than 1 second. 
High-K
+ 
solution was prepared by exchanging equivalent amount of Na
+ 
in ACSF. 
4.4 Organotypic culture 
For the preparation of organotypic culture we used 250 μm-thick brainstem slices which 
contained preBötC (see above). Mice were prepared at P2–P4 and P18–P20 (denoted hereafter as 
P3 and P19, respectively). The preparation itself and all further manipulations were conducted on 
ice in ACSF solution saturated with 95% O2 and 5% CO2. After preparation the slices were 
placed on support membranes. Neurobasal-A medium (1 ml) was added so that the surface of the 
slice was continuously exposed to the incubator gas mixture, and balance between respiration and 
nutrition was achieved. We found that the organotypic slice cultures survived best in the culture 
medium containing 50% MEM with Earle's salts, 25 mM HEPES, 6.5 mg/ml glucose, 25% horse 
serum, 25% Hanks solution buffered with 5 mM Tris and 4 mM NaHCO3, pH 7.3. This medium 
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was changed every other day. Maintenance of the slice on the boundary between medium and 
humidified carbonate atmosphere in a thermostat under conditions mentioned above allowed us 
to increase the life-time in the culture to up to 2 months without significant changes in viability 
or morphology. 
The morphology of neurons from WT and KO mice was examined in groups at an interval 
of 1 week starting from P14. Approximately equal numbers of neurons from the respective 
groups were measured in parallel. All data were acquired and analysed blinded to genotype. Each 
test in this study was repeated with at least four different preparations and the mean data were 
obtained by analysing responses of 6–12 neurons in the image field. After performing the 
experiments, the slices were fixed and the immunocytochemical analysis was made to reveal 
NK1 putative receptors as described below. For the immunocytochemical experiments the 
surrounding membrane was removed, slices were fixed on the 18 mm glass coverslip with acrylic 
glue (Loctite 401) and mounted in the experimental chamber on a microscope table and 
immobilized with silicon Basilone-paste 35 (GE Bayer) in order to avoid accidental movements 
during imaging. 
4.5 Immunofluorescence 
Transverse brainstem sections containing the respiratory kernel (Ruangkittisakul et al., 
2006) were examined in the presence of specific receptors using the antibodies to the tachykinin 
receptor 1 (TACR1) also known as neurokinin 1 receptor (NK1R) or substance P receptor (SPR). 
This G protein coupled receptor is abundant in neurons of the ventral respiratory group (Gray et 
al., 1999; Wang et al., 2001). NK1 receptor was proposed to endow specifically preBötC neurons 
for the following reasons: 1) immunohistochemical labelling for NK1R co-stains the population 
of glutamatergic respiratory neurons within the preBötC; 2) injection of Substance P, a putative 
NK1R ligand, into the preBötC markedly increases the respiratory frequency, and 3) a targeted 
destruction of NK1R-positive preBötC neurons with a toxic complex Substance P – aporin 
disrupts the rhythmic motor output in vivo (Gray et al., 1999; Gray et al., 2001; Manzke et al., 
2003; Stornetta et al., 2003; McKay et al., 2005;). Based on these observations, it is proposed that 




Figure 3. Anatomical localisation of preBötC in mouse brain stem.  
(A) Schematic drawing of a rostrocaudal section of the brain stem area, corresponding to the border 
between medulla and pons. PreBötC marked with green (modified from Lynch). (B) Schematic drawing of 
transverse section of the brain stem corresponding to preBötC. XII – Hypoglossal nucleus; IO – Inferior 
olive; Sp5 – Spinal trigerminal tract; NTS – Nucleus tractus solitarius. PreBötC marked with green. (C) 
Representative image of a spontaneously active neuron from preBötC region stained with fluo-3. 
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 For immunocytochemistry slices of the organotypic brainstem culture were fixed with 4% 
phosphate buffered formaldehyde (PFA). After a removal of the supporting membrane, the slice 
was permeabilized with 0.2% Triton X-100 for 30 min at room temperature (RT) and washed two 
times with phosphate buffer saline (PBS; pH 7.4). Non-specific binding was blocked with PBS 
containing 5% bovine serum albumin (BSA) for 1 h at RT. After washing three times with PBS 
(10 min each), the slices were incubated for 6 h at RT or, alternatively, 24–72 h at 4 °C with the 
primary rabbit anti-NK1R antibody solution (Chemicon; 1:200 in 2% BSA/PBS) followed by 
three cycles of washing for 15 min each. Slices were incubated for 4 h at RT in darkness with 
secondary Alexa 555-conjugated donkey antirabbit IgG antibodies (Molecular Probes; 1:500 in 
2% BSA/PBS) followed by extensive washing (three cycles, 30 min each). For the examination 
the slices were placed on microscope slides and covered with fluorescent mounting medium 
(DAKO). Neuronal immunofluorescence analysis was performed with a confocal laser-scanning 
microscope (Meta-LSM 510, Zeiss, Germany) using the wavelengths 488 nm (Ar/Kr laser) and 
543 nm (He/Ne laser). The overlay of two channels from confocal images (2048×2048 pixels) 
was merged using Zeiss software and imported into Adobe Photoshop CS2. 
4.5.1 Sensors 
Calcium imaging was performed with commercially available chemical sensors (fura-2 
and fluo-3 from Molecular Probes) and genetically encoded indicators (D3cpv, designed in the 
lab of Roger Tsien, see chapter 4.5.3 for further details). After loading the neurons with a sensor 
protein or expressing the protein indicator, the fluorescence was excited at appropriate 
wavelength and collected using Zeiss Axioscop microscope, captured by a CCD Andor iXon 
camera (ANDOR, Offenbach). 
4.5.2 Chemical indicators 
For imaging of intracellular calcium, 10 μM fluo-3/AM or 3 μM fura-2/AM were added to 
ACSF as the aliquot of DMSO-based stock solution. The staining mixture was sonicated and 
slices were incubated with the dye for 20 min at 37 
°
C, followed by a 30 minutes-long wash-out 
to allow deesterification of ester precursor. Spectra of excitation and emission for these Ca
2+
 
sensors and reporter proteins are presented in Fig. 4. Fura-2 was excited at 350 and 380 nm, fluo-
3 was excited at 470 nm and the emission of either dye was collected at 535 nm. Exposure times 
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Figure 4. Spectra of excitation and emission for the Ca
2+
 sensors and reporter proteins. 
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ranged from 300 to 500 ms and the frames were collected every 1 s and analyzed off-line using 
MetaMorph software (Universal Imaging Corporation, West Chester, PA, USA). [Ca
2+
]i increases 
were estimated from fluo-3 changes and from fura-2 ratios as described previously (Mironov and 
Hermann, 1996; Mironov and Langohr, 2005). Calcium changes were induced by applying 
membrane depolarisation with high-K
+
 (5 to 10 s), calcium release with 1 mM ATP (10 s), 
chemical hypoxia with application of KCN (200 μM 2 to 3 min), or evoking calcium release from 
internal stores (ER, 1 μM thapsigargin (Tg), and mitochondria 1 µM CCCP). All testing solutions 
were produced by adding aliquots of corresponding stock solutions directly to perfusing ACSF. 
4.5.3 Genetically encoded calcium indicators 
Calcium sensors are fluorescent proteins derived from green fluorescent protein or its 
variants (GFP, YFP, CFP), fused with calmodulin (CaM) and the M13 domain of the myosin 
light chain kinase, which binds CaM. Genetically encoded indicators are produced within cells 
after their transfection. We used calcium sensor D3cpv designed in the lab of Roger Tsien 
(Palmer et al., 2006; Palmer and Tsien, 2006; Wallace et al., 2008). In order to obtain a neuron-
specific transduction (Kügler et al., 2003; Shevtsova et al., 2005), the sensor was embedded into 
a recombinant adeno-associated virus (AAV) vector. For transduction, we applied 1 µl of AAV 
solution (≈1 x 10
9
 viral genomes) directly at the surface of the slice. The expression of D3cpv 
was detectable two days after transduction, reached a steady state after four to six days, and then 
remained constant over six weeks. D3cpv was excited at 430 nm by the LED (20 mW, Roithner 
Lasertechnik) generated light. Corresponding signals were separated with Optosplit (BFI Optilas, 
Puchheim) using dichroic mirror (495 nm) and 470 ± 12 and 535 ± 15 nm filters. Free calcium 
levels were obtained by rationing the emission of cyan fluorescent protein (CFP) at 470 nm to 
FRET signal between CFP and yellow fluorescent protein (YFP; emitted at 535 nm). Images 
were captured by a cooled CCD iXon camera (ANDOR, Offenbach) and collected with ANDOR 
software (500 x 500 pixels at 12 bit resolution). Fluorescence signals were analysed offline with 
the MetaMorph software (Universal Imaging Corporation, West Chester, PA, USA). Cytoplasmic 
calcium levels were evaluated from ratios of FRET and CFP signals (R) using the formula first 




          R - Rmin 
[Ca
2+
]i = Kd  ――――.      (1) 
                     Rmax  - R 
 
The dissociation constant Kd = 0.6 µM was taken from Palmer et al., 2004 and the values of Rmin 
= 1 and Rmax = 80 were determined from calibration experiments with ionomycin (Palmer and 
Tsien, 2006). D3cpv has better technical characteristics than fura-2 not only because it is 
selectively expressed in neurons, but also due to a broader range on Ca
2+
 dynamic detection (0.6–
6 mM) and greater resistance to photobleaching. This allows one to perform continuous imaging 
of the cells for about 1 h without significant deterioration of fluorescence signal. 
4.5.4 Genetically encoded cAMP indicators 
For cAMP imaging we used the sensor derived in the lab of Martin Lohse (Nikolaev et al., 
2004), namely Epac1-camps. It was excited at 430 nm with light generated by an LED (20 mW, 
Roithner Lasertechnik). Structure and emission spectrum of Epac1 fusion protein are presented in 
Fig. 5. Values of [cAMP]i were obtained from the ratio of Epac1-camps fluorescence (R) excited 
at 430 nm and emitted at 535 nm (FRET) and 470 nm (CFP). Calibration of cAMP levels in vivo 
using membrane-permeable 8-Bromo-2'-O-methyl-cAMP (BrOMecAMP), a specific activator of 
Epac (Kang et al., 2003) presented in Fig. 6B. Measured changes in ratio R were well fitted with 
the Michaelis–Menten–like equation 
        RmaxC  
R = ――――,      (2) 
        Kd + C  
where C is the concentration of nucleotide and Kd is the dissociation constant for Epac1-camps 
(Fig. 6B). In estimating Rmax we accounted for the basal [cAMP] level by making a calibration 
after suppressing AC activity with DDA (see Results, page 87). Absolute cAMP levels were 
obtained as 
           KdR  
C = ――――.      (3) 
       Rmax  - R 
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The basal [cAMP]i was 0.49 ± 0.03 µM (n = 16) whereas all [cAMP]i observed changes 
were well below 5 µM (Tables 3 and 4) indicating that the probe has an optimal dynamic range 
for cAMP imaging in neurons. One can see from Eqs. (2) and (3) that [cAMP] is approximately 
proportional to the measured ratio for [cAMP] levels which are less than Kd of the sensor (1.5 
µM, see below). Since this condition is not satisfied automatically, presentation of [cAMP] 
changes in the ratio form may show erroneous kinetics. 
Using previously described procedures (Nikolaev et al., 2004) we calibrated Epac1-camps 
protein in vitro. Briefly, HEK293 cells were transfected with Epac1-camps. Cells were washed 
three times and resuspended in 5 mM Tris, 2 mM EDTA, pH 7.4 buffer24 h after transfection. At 
the next step disruption with an Ultraturrax device for 40 s on ice and 20 min centrifugation at 
80000 rpm was performed. Fluorescence emission spectra of the supernatant (excitation at 436 
nm, emission range 460 - 550 nm) were measured with a fluorescence spectrometer LS50B 
(Perkin Elmer Life Sciences) before and after adding various concentrations of cAMP and a 
specific activator of Epac BrOMecAMP (Biolog Life Science Institute, Bremen, Germany). The 
concentration of fluorescent Epac1-camps protein was 50 nM. Ratios of FRET/CFP were 
calculated by dividing the peak emission intensities at 524 nm (FRET) and 477 nm (CFP) and 
analyzed using Origin 6.1 (Origin Lab Corporation, Northampton, MA, USA). The use of 
emission wavelengths with wider slits (such as set up in Optosplit) gave similar ratios. The 
curves for BrOMecAMP in vivo and in vitro were identical. They were close to the dose-response 
curve obtained for sensor in slices. Kd values in vivo and in vitro were 1.6 and 1.5 µM for 
BrOMecAMP, respectively, and 1.2 µM for cAMP. 
4.5.5 Simultaneous calcium and cAMP imaging 
During simultaneous calcium and cAMP imaging, we were concerned with possible 
contamination of the recorded fura-2 signal by CFP fluorescence from Epac1-camps which can 
be potentially excited by UV (Harbeck et al., 2006). Two pairs of Epac1-camps (470 and 535 nm 
emission at 430 nm excitation as presented in Fig. 5), and fura-2 signals (535 nm emission at 350 
and 380 nm excitation) recorded during the stimulation with high-K
+ 
are demonstrated in Fig. 6C. 
Imaging of cells which were not loaded with fura-2 demonstrated that excitation of CFP at 380 
nm produces the fluorescence at 535 nm that is only 10 ± 2 % (n = 24) of that recorded at 430 nm 
excitation. This estimation is in good agreement with the excitation spectrum of Epac1-camps in 
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vitro (Nikolaev et al., 2004). The two lowermost traces presented in Fig. 6C show the effect of 
such bleeding of Epac1-camps fluorescence into the fura-2 channel. Offline subtraction of 15 % 
Epac1-camps signal (Ex 430 nm, Em 535 nm) from the signal recorded in fura-2 channel (Ex 380 















Figure 6. Calibration of cAMP levels in neurons (from Mironov et al., 2009b). 
(A) Increases in 470/535 nm emission ratio during sequential addition of specific membrane-permeable 
Epac agonist 8-Bromo-2‟-OMe-cAMP. (B) Calibration of Epac-1-camps. Mean ratios ± S. E. M were 
obtained for 8-Bromo-2‟-OMe-cAMP in vivo and in vitro, and for cAMP in vitro. The data are plotted 
against nucleotide concentration and the smooth curve is drawn according to the Michaelis – Menten-like 
equation with Kd = 1.5 µM. (C) Typical Ca
2+
-dependent changes in [cAMP] after membrane 
depolarisation. The raw traces of Epac-1-camps emission at 470 nm (CFP) and 535 nm (FRET) excited at 
430 nm and of fura-2 emission at 535 nm excited at 350 and 380 nm as indicated. The lower two traces 
demonstrate changes in the fura-2 ratio at excitation wavelengths 350 and 380 nm and changes obtained 
after subtraction of 15 % of Epac1-camps signal (Ex 430 nm, Em 535 nm) from fura-2 signal (Ex 380, Em 
535 nm). 
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4.6 Transduction of neurons 
Adeno-associated virus of the mosaic serotype 1/2 was constructed as described 
(Shevtsova et al., 2005; Kügler et al., 2007). The vector genome consisted of AAV-2 inverted 
terminal repeats flanking the neuron-specific human synapsin1 gene promoter (Kügler et al., 
2001); EGFP, the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) for 
enhanced transgenic expression and a bovine growth hormone polyadenylation site (Fig. 7). This 
virus demonstrates greatly enhanced transduction of neurons in primary culture and was thus 
chosen for gene transfer into living slice cultures (Shevtsova et al., 2005). 
The slices were transduced at 3 to 6 DIV, when they acquired a flattened form and 
became more transparent, and when cells damaged during dissection, de- or regenerated. For 
transduction, we applied 1 μl of AAV solution (1×10
9
 viral genomes) directly to cover only the 
slice surface. When AAV diffused into the slice, expression of EGFP became detectable after 24 
h. It reached maximum 5 to 7 days after transduction and remained stable thereafter. The slices 
were taken into experiments at the times corresponding to about P12–P18 in vivo. We noticed no 
significant differences in the functional properties of the slices within this life span. 
All chemicals used fot transduction were from Sigma (Deisenhofen) and the fluorescent 
probes were from Molecular Probes (Leiden, Netherlands). Each test in this study was repeated 
with at least four different preparations. 
 
Figure 7. Structure of AAV vector (after Shevtsova et al., 2005). 
ITR – Inverted terminal repeats of AAV-2; Int – 146 bp chimeric intron; SV40 – Simian virus 40 derived 
polyadenylation site; WPRE – Woodchuck hepatitis virus post-transcriptional 3′-control element; bGH – 
3′-control element - bovine growth hormone derived polyadenylation site; hSyn1 – Short human synapsin-
1 gene promoter; Reporter gene – Independent expression cassette for green fluorescent protein (EGFP). 
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4.7 Patch clamp 
Ion channels are known to mediate a controlled passage of ions through the membrane 
that underlies many forms of cell communication. Specialised structure within channel pores 
allow them to switch between open and closed state, determined by intrinsic properties of the 
channel protein which can in turn be changed by various intracellular signaling pathways. The 
channel behavior is controlled either chemically (ligand-gated channels) or electrically (voltage-
gated channels in excitable cells). However, the basic pattern is the same for any type of channel: 
when the gate opens, the current flows across the membrane; it stops when the gate is closed. 
 Despite these properties of ion channels were foreseen, the confirmation was acquired 
only after introduction of patch-clamp method representing a unique tool to examine properties of 
single ion channels. Openings and closings of the channel produce two different current levels 
that correspond to two membrane conductunces. The probability of opening of the channel 
(which is a function of the number of openings and their duration) depends on the control 
mechanism which is determined by intrinsic properties of the channel protein and cell potential 
itself. These factors can be changed while representing a cellular reaction to various 
physiologically relevant processes. 
In our studies we examined ATP sensitive potassium (K-ATP) channels that are abundant 
in neurons and other cells (Richter et al., 1993). Their opening probability directly depends on the 
intracellular ATP/ADP levels. It means that they are directly coupled to the metabolic state of a 
neuron to its electrical activity. K-ATP channels were described and characterised in the 
respiratory neurons (Mironov et al., 1998; Haller et al, 2001) and their physiological role in 
glucose sensing (Yamada and Inagaki, 2002), brain hypoxia (Mironov et al., 1998), and chronic 
neurodegenerative diseases (Liss and Roeper, 2001; Soundarapandian et al., 2001) are well 
established. 
Patch-clamp recordings were performed on 5-10-days-old cultured neurons and 4-14 days 
old organotypic slices under visual control. Coverslips were placed in a perfusion chamber of a 
microscope with a continuous flow of ACSF. Perfusion was maintained by a cassette pump 
coupled with water heating system that maintained a constant temperature 34 °C in the 
experimental chamber. Pipettes were manufactured from a borosilicate glass capillars (Clark 
Instruments, Pangbourne, UK) using horizontal micropipette glass puller. Their tip openings had 
diameter of 1.5–2 μm and resistances of 1.5–2.5MΩ. The electrodes were filled with intrapipette 
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solution contained 140 mM D-gluconic acid, 0.5 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 1 
mM NaCl, 1 mM EGTA and 1 mM Na2ATP, with pH adjusted to 7.4 with KOH. 
When approaching the cell, a gentle pressure was applied to prevent the tip from 
incidental contact with the cell or cell debris. For the gigaseal formation, the electrode was 
centred above the chosen cell and a gentle sucking was applied to stimulate the formation of a 
gigaseal (generally with resistance higher than 2 GΩ) in cell-attached recordings. The whole-cell 
mode was obtained by rupturing the plasma membrane. 
K-ATP channels were measured in the cell-attached mode at a range of holding potential 
from 0 to -50 mV together with the action potentials indicating the activity of the cell. 
Intracellular signals were amplified through an EPC-7 patch-clamp amplifier (ESF, Friedland, 
Germany) as described previously (Mironov et al., 1998). They were filtered at 3 kHz (-3 dB) by 
L/M-PCA amplifier (E.S.F, Friedland, Germany), digitized and transmitted with Pulse program 
(Acquisition interface LIH 1600 by HEKA Elektronik) and stored for further off-line analysis. 
Single-channel data measured in a cell-attached mode were presented with the inverted currents, 
i.e., their values were assumed to be the difference between the value inside and outside the cell, 
according to conventional definitions of voltage and current directions in the neuron. 
All patch-clamp data were primarily analyzed in QuB program (Version 1.4.0.2. The State 
University of New York, Buffalo, NY, USA) using principles of Markov model. Long-lasting 
single channel recordings were splitted to sequence of 2s intervals that were analyzed separately. 
Obtained parametras of each interval such as number of channel openings, probability of open 
state and mean duration of open state were transferred into Excel (Office XP Professional, 
Microsoft Deutschland GmbH, Unterschleißheim, Germany) for further statistical analysis. Data 
with action potentials were analyzed separately, while in that case we were interested only in 
number of events. Based on these calculations three time intervals of the same length vere chosen 
for further analysis and mean data from these intervals were obtained. Graphs and diagrams were 
plotted in Matlab and Excel based upon these values. 
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5. Results 
In our electrophysiological study we used primary cultures of both cerebellum granule 
cells and preBötC neurons. These areas of brain are thought to be involved in the RS 
development and appear to be preferentially affected from the standpoint of both neuropathology 
and clinical signs (Oldfors et al., 1990; Murakami et al., 1992). The most characteristic aspects of 
RS-based changes in these areas should be connected with specific neuronal dysfunctions of 
cerebellum and preBötC involved the control of motor reflexes and rhythmogenesis. To unravel 
possible differences in neuronal network activity in the mouse RS model, we examined patterns 
of channel and neural activities. In what follows, we describe the effects of modulation of K-ATP 
channels in cerebellum granule cells and preBötC neurons via G-protein coupled receptors 
(ATP), neurotrophins (BDNF), as well as regulation of action potentials in the spontaneously 
active neurons in cerebellum and in preBötC and in particular their changes during development. 
The results obtained in isolated cells in the primary neuronal culture of cerebellum and preBötC 
were then complemented by studies of the organotypic slices, which more close correspond to the 
native nervous tissue. 
5.1 ATP-dependent potentiation of K-ATP channels 
Most single-channel recordings were made at the -20 mV holding potential that would 
roughly correspond to channel activity at rest. All recordings were made in the cell-attached 
mode, as described above in section 4.7 “Methods”. Application of ATP induced in both 
cerebellum and preBötC neurons gave rise to two effects: 1) fast activation followed by 2) slow 
inhibition of channel activity. The former was indicated by an increase in the probability of 
channel opening (Fig. 9A traces 2, 3) and attained its maximum in the interval of 10 to 30 s after 
ATP was introduced into the bath medium (Fig 9B, phase 2, Fig. 9 C). This short activation was 
then replaced with the inhibition of the channel activity which developed slowly and was long-
lasting (Fig. 9 B, phase 3). The ATP–induced decrease in K-ATP channel activity (Fig. 9A trace 
6) emerged 40 s after the application and the initial levels of channel activity were achieved only 
after washing out ATP for 10 to 15 s (Fig. 9A trace 4). Repetitive applications of ATP to the 
same cell induced smaller effects (Fig. 9A trace 5), but the time to recover from inhibition 
increased from about ~20 s to no recovery at all. This effect likely reflected certain underlying  
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Figure 9. ATP-dependent modulations of the activity of K-ATP channels. 
(A) Cell-attached patch clamp of cerebellum granule cell demonstrated ATP-induced changes in K-ATP 
channel activity. Initially active cell (1) treated with ATP (2) showed increase in channel activity (2, 3). 
Enhanced response of the same cell to the second exposure to ATP (4, 5) was fully reversible. Recovery 
developed after apr. 10 minutes of washout (6). Traces (7, 8) represents slowly-developing effect of ATP-
based inhibition. Closed state of the K-ATP channel referred to a “<” sign. (B) Mean number of events 
(e.g  K-ATP channel openings) on each stage of developing effect demonstrated ATP-induced changes in 
K-ATP channel activity. Mean number of events in intact cells was referred to 1. Phase 1 illustrated mean 
initial activity of cells, phase 2 referred to mean activity at a stage of fast activation, phase 3 – to mean 
activity at a stage of slow inhibition of the channels. (C)  Distribution of channel activity during the time 
demonstrated that most peaks of activity arised during interval of 25s (marked on x axis with grey). This 
fact  allowed us to define time intervals for further analysis (phase 1, 2, 3). Number of all events during 
whole period of observation was defined here as 100%. . Experiments have been performed under -20mV 




   
n=5 
Figure 10. ATP-dependent modulations of APs activity. 
 
(A) Actipon potential frequency is modulated by ATP in spontaneously active respiratory neuron from 
preBötC. Intact cell that spontaneously generates APs (1) exhibiteted primary effect of ATP application 
with the decrease in the number of spikes during the interval (2). Secondary, longer-developed ictivating 
effect of ATP application (3, 4) was followed by suppressed activity of spontaneously active cell (5). 
Constant frequency is typical for respiratory pacemaker cell. Experiments have been performed under -
20mV of holding potential. (B) Mean number of APs on each phase of developing effect demonstrated 
ATP-induced changes in bursting activity of spontaneously active cells. Mean number of APs per second 
before ATP was added to the medium was referred to 1. Phase 1 illustrated mean initial activity of cells, 
phase 2 referred to mean activity at a stage of ATP-dependent activation, phase 3 – to mean activity at a 
stage of slow inhibition.  
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biochemical processes which developed slowly and were fully activated after several applications 
of ATP (Fig. 9A trace 7). However, the two subsequent applications of ATP were found to be 
reversible. 
 
5.2 ATP-dependent modulation of action potentials 
Patch-clamp recordings in cell-attached mode allow one to record the action potentials 
showing the patterns of intrinsic neuronal activity. Application of ATP to spontaneously active 
preBötC neurons and bursting cerebellum granule cells induced specific changes in their activity. 
The burst frequency was not changed by ATP, but the number of spikes per burst decreased (Fig. 
10 A) and 30 s after adding ATP into the medium a clear depress ion of neuronal activity was 
observed indicating a slowly-developing inhibition effect (Fig. 10 A, B). 
5.3 BDNF modifies activity of K-ATP channels  
Next we examined the effects of BDNF, a neurotrophin that plays an important role in the 
development of Rett Syndrome. Its application to the neurons also produced two different effects 
on K-ATP channel activity: 1) fast-developing activation that took place during the first 2 
minutes after BDNF had been added into the medium and 2) slowly developing inhibition that 
lasted up to 30 minutes. Fast BDNF dependent activation both in cerebellum and preBötC 
neurons was a result of an increase in the open probability of the channel (Fig.11A, B). Such 
potentiation developed about 1 min after BDNF addition and lasted for about 20 to 30 s (Fig. 
11A, trace 2, Fig 11B, phase 2); after that a repression of channel activity was observed (Fig. 
11A, trace 3, Fig 11B, phase 3). A decrease in the channel activity was manifested by an 
appearance of long-term closures (Fig. 11A trace 4) that reached the maximum after about 2 min 
and lasted for 5 minutes. Washing out BDNF for 10 to 30 minutes relieved the inhibition. The 
main effect was a steady disappearance of the long closures of the channel accompanied by an 
increase in the channel open time. Notably, a decrease in the lengths of closures resulted in the 
irregular pattern of channel openings (Fig. 11A, trace 6). A partial recovery took about 20 
minutes; however, after 50 minutes of washout the long-lasting periods of inactivation were still 
present. Such events were not typical for “naïve” cells which had not been subject to BDNF 
before.
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Figure 11. Modification of the K-ATP channel activity by BDNF.  
(A) Recording of cell-attached patch clamp represents BDNF dependent modulation of the activity of K-
ATP channel of granule cell from cerebellum. Initial K-ATP channel activity (1) is changed to the fast-
developing BDNF-based activation of the channel (2) with decrease in inactive periods and increased 
number of opening per second. Activation of K-ATP channel (2) substituted by long-developing effect of 
inhibition (3), long silencing periods arise. Development of BDNF-based inhibition (4) results in the long-
term inhibition (5) with continuous silencing periods (6). Full recovery (7) takes place after 20 minutes of 
washout. Closed state of the K-ATP channel referrs to a “<” sign. Experiments were conducted under -
20mV of holding potential. (B) Mean number of K-ATP channel openings on each stage of developing 
effect demonstrated BDNF-induced changes in K-ATP channel activity. Mean number of channel 
openings in intact cells was referred to 1. Phase 1 illustrated mean initial activity of cells, phase 2 referred 
to mean activity at a stage of activation, phase 3 – to mean activity at a stage of inhibition of the channels. 
Time intervals that were analysed as phase 1, phase 2 and phase 3 were defined by the same algorithm as 
for ATP-induced effect.. . Experiments have been performed under -20mV of holding potential. 
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5.4 BDNF modulates excitability of granule cells and preBötC neurons 
Spiking neurons of the primary neural culture were incubated with BDNF for at least 5 
minutes to reveal BDNF-dependent modification of the APs development. Whole-cell recordings 
showed fast temporary increase in the frequency of action potentials (Fig. 12A trace 2, recorded 
at -50 mV of holding potential, Fig. 12C phase 2). This effect developed for 20-40 s (Fig. 12D) 
and then led to the transformation of burst activity into tonic activity within next 3-5 minutes 
(Fig. 12A trace 3, Fig. 12C). At the same time depression of action potentials was clearly seen 
(Fig. 12A traces 4, 5). This reduction of signalling activity was irreversible in 90% of cases. In 
less than 10% cases the initial level of activity was retained, although the origin of spikes was 
different. APs were not coupled as it was seen for the intact cells of the primary culture (Fig. 12A 
traces 5, 6). This allows us to speculate upon the possibility of a BDNF-dependent 
desynchronization of the spontaneous activity. BDNF-based effect on spontaneously active cells 
developed from the same origin in both cell cultures (Fig. 12B). In case of initial organisation of 
APs in bursts in preBötC neurons, effect of desynchronization was seen much more obvious (Fig. 
12B traces 4, 5). In this case continuous washout was not efficient, because partial 
desynchronization remained even in 60 minutes after BDNF removal (Fig. 12B trace 6). This 
suggested that neurons producing bursts of APs (mainly respiratory neurons of preBötC) were 
more sensitive to BDNF. The latter suggestion had been proved by the previously obtained data 
from rhythmic slices (Thoby-Brisson et al., 2003; Bouvier et al., 2007) showing higher sensitivity 
of preBötC neurons to incubation with BDNF. 
5.5 Interactions between ATP and BDNF signalling pathways 
Since ATP and BDNF produce similar biphasic effects on channel activity, next we 
examined the crosstalk between the underlying pathways. The agents were sequentially applied in 
the same and reverse order and the resulting patterns of channel activity were examined. Addition 
of ATP to granule cells of cerebellum in the presence of BDNF did not change the pattern and 
time-course of the effect on channel activity. At the same time the open probability of K-ATP 
channels slightly increased that might result from complimentary actions of ATP and BDNF. The 









Figure 12. Modification of the Aps activity by BDNF. 
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(A) BDNF dependent modulation of excitability of granule cells (1) with fast-developing activation of 
spontaneous activity (2) substituted with tonic activity (3). 4, 5 – Slowly-developing augmentation of 
action potentials (3, 4) and desynchronization of currents develops in the end of incubation period (4, 5) 
was not fully reversible. After 60 minutes of washout action potentials are still inhibited (6), no bursts of 
spikes can be seen, desynchronization still persists. Experiments were conducted under -50mV of holding 
potential. (B) BDNF-based modulation of APs of the spontaneous active (1) neuron form preBötC. Spikes 
are grouped in bursts and the activity of the cell is enhanced during 20 s after addition of BDNF which is 
referred to the fast activation (2). Fast-developed activation is substituted by slowly-arising inhibitory 
effect (3, 4). Note uncoupled currents appearing after 40 s (4, 5). The lowermost trace (6) demonstrates 
partial desynchronizatoin still remaining after 60 minutes of continuous washout. Experiments were 
conducted under -50mV of holding potential. (C) Mean number of APs on each phase of developing effect 
demonstrated BDNF-induced changes in activity of spontaneously active cells. Mean number of APs 
before BDNF was added to the medium was referred to 1. Phase 1 illustrated mean initial activity of cells, 
phase 2 referred to mean activity at a stage of BDNF-dependent activation, phase 3 – to mean activity of 
the cells at a stage of slow inhibition. (D) Distribution of AP activity during the time demonstrated that 
most peaks of activity developed during interval of 18-20s after BDNF was added (marked on x axis with 
grey). This fact allowed us to define time intervals for further analysis (phase 1, 2, 3). Number of all 
events during whole period of observation was defined here as 100%. 
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the open probability was evident due to an increase in the number of opening events during the 
periods of high activity (Fig. 13A traces 4 and 3 respectively, Fig. 13C traces 4 and 2). Although 
the short-time activity of the K-ATP channels seemed to enhance dramatically, an overall 
increase in channel activity was not appreciably augmented due to the existance of long closures 
in the presence of BDNF (Fig 13E). This indicates that the long-term BDNF modulation of the 
K-ATP channel persists even when the channel activity is seemingly recovered. On the other 
hand, in the presence of ATP the time-course of the BDNF effect was clearly different from the 
one observed in the naive cells (Fig 13F). However, although the pattern of the response was the 
same, the response to BDNF was developed about 60% faster (Fig. 13F). 
The changes in neuronal responses to BDNF and ATP were modified after pre-incubation 
with cholera toxin (CT, 50 ng/ml 3.5-5.5 h), blocking GTPase-aktivity of inhibitory G-protein. 
They are coupled to adenylate cyclase and through this blockade adenylate cyclase becomes 
permanently activated that leading to elevation of cAMP. The experiments performed together 
with Sebastian Gliem (ENI rotation) demonstrated that after a pretreatment with the toxin, the 
number of channel openings and the open state probability decreased almost twice (from 4.1 – 
21.5% to 1.4 – 1.8% per second). It is plausible that the changes in ATP-mediated effects arise 
from the selective inhibition of signal transduction between P2Y receptors and G-proteins. Since 
CT also modified the response to BDNF, the BDNF-dependent modulation of K-ATP channels 
can be also attributed to modification of G-protein / P2Y-receptor interplay. This complements 
the previous conclusion that in preBötC cAMP increase suppresses activity of K-ATP channels 
that in turn reinforces the respiratory motor output (Mironov et al., 1999). 
5.6 The electrophysiological study of Mecp2 null mice 
Modulation of K-ATP channel and neuronal activities by ATP and BDNF in cerebellum 
granule and preBötC cells were qualitatively similar. In Mecp2 null mice the activity of K-ATP 
channels was much reduced (Fig. 14B). This effect is manifested by distinctly lower probability 
of opening. The activation of K-ATP channels leads to membrane hyperpolarization and 






     
Figure 13. Differences in channel responses during multiple applications of ATP and BDNF.  
Four applications of either ATP or BDNF on the same cell under the same holding potential of -20 mV are 
demonstrated. Grey line referrs to the closed state of the channel. (A) Primary application on cerebellum 
granule cell (1). Incubation with BDNF represented typical combination of fast activation (2, 3) and slow 
augmentation (4, 5) due to developed periods of silence. (B) Secondary application of ATP resulted in the 
overlapping effects: periods of silence still remained (1, 3) but the activity of the channel increased (2, 3). 
(C) BDNF application on the same cell demonstrated slightly enhanced effect of both activation (1, 2) and 
inhibition (4, 5) of channel activity. Periods of silence were much longer (3, 4) and developed faster than 
during the first application. (D) ATP-dependent activation of the same cell resulted in the change in the 
kintetics of response. Period of ATP-dependent activation was longer (2, 3, 4, 5) even though it was 
overlapped with inhibitory effect of BDNF (long pauses at traces 4 and 5) period of ATP-dependent 
activation lasted longer than those for the single incubation with ATP. Panels (E) and (F) presented  
comparacement of effect of primary and secondary application on number of channel openings. Mean 
number of events before reagent was added to the medium was referred to 1. Phase 1 marked with light 
grey illustrated mean initial activity of cells, phase 2 (dark grey) referred to mean activity at a stage of 
BDNF-dependent activation, phase 3 (black) – to mean activity of the cells at a stage of slow inhibition. 
Intervals corresponding to phases were defined based on the origin of first application. 
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Brown, 2004). This means that Mecp2 -/y neurons should possess an enhanced excitability as 
compared to the wild-type neurons. Such differences may underlie intrinsic disturbances in 
calcium and cAMP homeostasis in Mecp2 -/y neurons as described below. Notably, after 
pretreatment with exogenous BDNF K-ATP channels in the Mecp2 -/y neurons showed activity 
which was close to that observed in the wild-type (Fig. 14C). 
Patch-clamp recordings performed in organotypic brainstem slices showed that both ATP 
and BDNF elicited the effects similar to those observed in the primary culture of preBötC neurons. 
This substantiates the results of detailed investigations of K-ATP channels in culture suggesting 
common operating mechanisms. The only difference between the effects in slices and in culture 
was the time-course of the responses that can be attributed to a slower delivery of the drugs to the 
bulk of the slice. The increased vulnerability of Mecp2 null neurons due to weaker activity of 
„protective‟ K-ATP channels may influence the development of synapses. The positive effects of 
BDNF indicate that the improper development and disorders, caused by low concentration of 
BDNF in both cerebellum and brain stem (preBötC), responsible for locomotion and respiratory 
rhythm generation, respectively, can be compensated. Thus the subcellular effectors of BDNF, 




Figure14. Appearance, channel activity, and BDNF-dependent potentiation of the Mecp2 null 
neurons. 
(A) Mecp2 -/y neurons from preBötC (1) and from cerebellum (2) in culture. (B) Decreased activity of 
K-ATP channels in preBötC neurons from Mecp2 y/- mutant. (C) Long-term potentiation of channels 
after application of BDNF (20 ng/ml for 5 min). Note that potentiation persisted 10 min after BDNF 
was washed out. The data indicate decreased expression of K-ATP channels in the KO cells that can 
underlie enhanced excitability in ‘Rett‟ mice and its apparent correction by BDNF. 
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5.7 Distorted topology of the network in preBötC in model Rett mice 
Neuronal organisation and function of cerebellum and brain stem are severely distorted 
in Rett syndrome. The changes develop in humans within first 6 to 18 postnatal months that 
corresponds to about 2 postnatal months in mice. Many factors participate in 
neurodevelopment and their actions frequently involve specific changes in the concentration of 
two second messengers, namely calcium and cyclic AMP, which regulate underlying processes 
either up- or downstream. We therefore examined the mechanisms of calcium and cAMP 
homeostasis and how they were related to neurodevelopment in Rett Syndrome using a model 
Mecp2 null mice. We tested whether BDNF was able to correct the disturbances in calcium and 
cAMP regulation. 
A low-resolution (x10) image of a transverse brainstem slice transduced with neuron-specific 
fluorescent Ca
2+
-sensor D3cpv is shown in Fig. 15A. It demonstrates the organisation of 
neurons in the transverse slice and location of preBötC and other anatomical markers. At 
higher resolution (x40) fine details of neuronal processes are revealed (Fig. 15B, C). Images 
that were obtained using selective expression of calcium sensor in neurons sharply contrast 
with those obtained by bulk loading of slices with conventional calcium probes such as fura-2 
(Hartelt et al., 2008), which are blurred leaving only neuronal somata visible. In contrast, the 
D3cpv sensor completely filled the interior of neurons after expression with only slight 
regional variations that allowed us to perform analysis of network wiring. The images were 
thresholded to produce contiguous masks of neurons (see the insets in Fig. 15B). The wiring 
diagrams within network were generated by applying the algorithms described previously 
(Hartelt et al., 2008). In the preparations of organotypic slices of preBötC from the WT mice, 
the morphology of neurons and their organisation was not changed significantly within the first 
two postnatal months. On the contrary the network in KO mice was apparently reorganized 
during this period of time, namely, the number of neurons and connections decreased as 
compared to those in WT. Such changes in the organisation of the network during the first 
month are presented in Fig. 15C. Already at P14 (that corresponds to 11 DIV in a preparation 
made at P3) these values were significantly smaller and the differences between WT and KO 
became even greater at later examination times. KO neurons had smaller dimensions (mean 
diameter was 14.1 ± 1.2 vs. 19.2 ± 1.4 μm at P28, n = 64, P < 0.05), that, among other 
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Figure 15. Topology of the WT mice respiratory network and its modification in Mecp2 null 
mice (Mironov et al., 2009a). 
(A) Image of the transverse WT slice transduced with AAV-D3cpv at P28 (left) and schematic 
presentation of main anatomical nuclei (right) in this brain stem section (NA – Nucleus ambigus, XII – 
Nucleus hypoglossus, NTS – Nucleus tractus solitarii, preBötC – pre-Bötzinger complex). (B) Part of 
preBötC region in WT and Mecp2-/y (KO) mice at P21. The binary images shown in right upper insets 
were used to obtain the wiring diagrams within a preBötC network. Nodes (the cell bodies) are 
indicated by red circles. The lines approximate interconnecting neural processes and represent the edges 
of the network. In these two images of WT (KO) network 20 (14) nodes and 25 (18) edges were 
counted. (C) Typical appearances of preBötC network at different postnatal days in culture. 
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morphological features, represents a morphological hallmark of RS both in mice (Larimore et 
al., 2009) and humans (Wenk, 1997). All slices were transduced during the first postnatal 
week. The neurons in slices maintained production of the sensor in the culture. Hence one can 
conclude that these changes in morphology cannot be related to the differential expression of 
D3cpv in WT and KO preparations. Culturing conditions might have influenced the difference 
in maturation between WT and KO neurons. To exclude this possibility, the slices from both 
types of mice were prepared at P19 and the measurements were repeated. Appearances of slices 
in the two preparations as well as morphological data were similar at the same postnatal day. 
Similarity of the overlapped data obtained in P3 and P19 slices justifies the absence of 
particular changes in the developmental program in culture as factors that might explain the 
differences between WT and KO mice. When the slices derived from P3 KO mice were 
cultured in the presence of BDNF (10 ng/ml), the number of neurons and connections showed 
no significant differences from those in WT mice. This fact indicates a positive influence of 
BDNF during the maturation of KO slices. These data are in agreement with the fact that RS is 
connected with the deficiency in BDNF production and secretion (see subsection 3.5.6 
Introduction for further details). Morphological changes in the brainstem cytoarchitecture of 
the Rett mice are probably caused by intracellular calcium that is known to participate in the 
processes of neuronal maturation, shaping, and synaptogenesis. Ca
2+
 resting values were higher 
in all KO preparations (compared to WT); and this might result in reduction of the number of 
connections and in smaller dimensions of KO neurons. Both effects were corrected to the 
normal values by incubation with BDNF (Fig. 16C) which acts as a factor for neuronal 
surviving. This effect of BDNF also supports electrophysiological observations described 
above and shows a long-term activation of „stabilizing‟ K-ATP channels. After pretreatment 
with exogenous BDNF, the KO neurons acquired wild-type patterns such as their channel 
activity. Elevated resting [Ca
2+
]i levels point to particular disturbances in calcium homeostasis 
in KO neurons that may be responsible for the long-term changes observed in the morphology 
of neurons and their connectivity. 
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5.8 Impaired Ca2+ homeostasis in MeCP2 deficient neurons and its 
correction by BDNF 
Resting [Ca
2+
]i is normally controlled by the processes of slow Ca
2+
 buffering which 
includes specific transport systems in the ER, mitochondria, and plasma membrane. All these 
participating systems are also active at rest, therefore any changes in basal [Ca
2+
]i levels 
indicate a modification of one or more of mentioned above transporting mechanisms. Slow 
buffering of Ca
2+ 
is effectivelly examined by analysing the amplitude and time-course of the 
depolarisation-evoked calcium transients. To the first approximation, the rate constant of 
[Ca
2+
]i recovery from the steady state (=1/τ where τ is the time constant) is a sum of rate 
constants of all participating systems (Mironov, 1995). The maximum amplitude (a new steady 
level attained during depolarisation) is determined by the product Jτ where J is the Ca
2+
 influx 
into the cell. 
For in vivo calcium measurements we used the neurons which demonstrated periodic 
activity in the form of rhythmic calcium transients accompanying the bursts of action potentials 
in spontaneously active cells in our preparation (for further details see Hartelt et al., 2008). In 
KO neurons the transients had bigger amplitudes than in WT neurons (0.16 ± 0.02 vs. 0.09 ± 
0.02 µM) and slower recovery time constants (5.1 ± 1.2 vs. 3.1 ± 0.8 s). The above numbers are 
the mean values for 24 neurons of each sort (n=24). Depolarisation with high-K
 +
 evoked 
bigger transients with a slower decay (the mean amplitudes and recovery time constants in WT 
and KO neurons were 0.25 ± 0.3 vs. 0.39 ± 0.4 µM and 6.1 ± 0.2 vs. 11.1 ± 0.2 s, respectively, 
n = 24). Such difference in time constants for spontaneous and evoked calcium transients can 
be explained by shorter duration of spontaneous bursts, after which the recovery of [Ca
2+
]i is 
faster. In this case initial rates of Ca
2+
 do not attain homogeneous distribution in the cytoplasm 
and Ca
2+ 
is additionally redistributed through diffusion after the Ca
2+ 
influx ceases. Differences 
in kinetics for spontaneous and evoked calcium transients depend not only on faster recovery of 
[Ca
2+
]i after spontaneous bursts, but also on each cell‟s size and geometry and give variable 
contributions to the time constants. In order to exclude these effects, we analysed the kinetics 
of calcium recovery after 5 s-long depolarisations. Such depolarisations resulted in uniform 
steady [Ca
2+





Figure 16. Calcium transients in WT and MeCP2 deficient mice (Mironov et al., 2009a). 
(A) Typical depolarisation-induced calcium transients in spontaneously active preBötC neurons evoked 
by application of 50 mM K
+ 
for 5 s. (B) The same transients are presented as semi-log plots to show the 
extended time-course of decay in KO mice. (C) Mean decay time-constants and peak increases during 
depolarisation, obtained in 6 to 8 different preparations at P21. 
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Fluorescence signals recorded in both KO and WT preparations had similar amplitudes 
and identical minimum and maximum values during calibration of with ionomycin (see Fig. 6). 
Thus one can conclude that the changes in calcium levels and time constants of recovery 
between WT and KO neurons were not due to differential expression of D3cpv sensor or 
changes in its properties. 
Mitochondria and ER are the main systems of slow calcium buffering. We analysed their role 
by applying protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP), a respiratory 
chain uncoupler, and thapsigargin (Tg), a sarcoplasmic reticulum Ca
2+
-ATPase (SERCA) 
inhibitor. These agents released Ca
2+ 
from the corresponding internal store and significantly 
increased both the peak amplitude and time constant of recovery after depolarisation (Fig. 17A-
D). Notably, in the KO neurons that were maintained in culture in presence of BDNF (10 
ng/ml), the depolarisations-evoked calcium transients acquired the time-courses and amplitudes 
identical to their WT counterparts. At P28 the respective mean values (n = 12) were 6.4 ± 0.5 s 
vs. 7.1 ± 0.6 s and 0.26 ± 0.06 µM vs. 0.29 ± 0.07 µM in WT and KO. The same results were 
obtained at P14 and P2. On the other hand, pretreatment of WT slices with TrkB blocker 
K252a produced opposite effects, and calcium transients acquired the form typical for KO 
neurons (Fig 17G, H). The specificity of TrkB blockade was confirmed by applying the 
inactive analogue K-252b, which showed no effects (n = 4). 
Application of BDNF alone always induced an immediate transient increase and 
subsequent slow [Ca
2+
]i decrease (see Fig. 18). Both effects were related to Ca
2+
 handling by 
ER. They did not depend on extracellular Ca
2+
 because they were abolished after application of 
thapsigargin and they were not affected by CCCP. The fast transient to BDNF represents a Ca
2+ 
release (Bramham and Messaoudi, 2005; Lang et al., 2007), because this effect was not 
observed after activation of metabotropic receptors with ATP, t-ACPD, substance P nor in the 
presence of thapsagargin, each of which depletes ER Ca
2+
. Depolarisation-induced calcium 
transients recorded during the secondary long-lasting decrease had smaller amplitudes and rates 
of decay (Fig. 18B) and resembled the responses of WT neurons. The data obtained indicate 
that BDNF stimulates SERCA that in turn improves calcium removal from the cytoplasm. 
















Figure 17. Contributions of mitochondria and ER to the slow calcium buffering in preBötC 
neurons (Mironov et al., 2009a). 
Depolarisations with 50 mM K
+
 were induced before and 2 min after applications of 1 µM CCCP (A, C, 
E, G) and 1 µM Tg (B, D, F, H). Uncoupling of mitochondria with CCCP and inhibition of SERCA 
with thapsigargin led to an increase in basal calcium levels and prolonged the decay of calcium 
transients after membrane depolarisation in both wild-type and KO neurons. After pretreatment with 
BDNF (20 ng/ml, 20 min), the time-courses of transients in KO neurons became closer to those 
measured in WT cells (E, F). After pretreatment with TrkB blocker 100 nM K252a for 20 min, the 
transients in WT neurons acquired the amplitudes and decay times typical for KO neurons (G, H). Time 
constants of [Ca
2+
]I recovery obtained in 15 to 25 neurons presented in the histograms on the right 




        
Figure 18. BDNF and calcium homeostasis (Mironov et al., 2009a). 
(A) Initial transient increase and long-lasting [Ca2+]i decrease during BDNF application. (B) 
Representative calcium transients due to depolarisation recorded at P28 in wild-type and MeCP2 
deficient slices and in WT slice treated with 100 nM K252a. Semi-log plots near original traces show 
the differences in [Ca
2+
]i recovery times. The traces recorded in the presence of BDNF are grey-coded 
(online, blue). 
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5.9 Hypoxia and retraction of neurites 
Respiratory network function in RS mouse models shows disturbances consisting of 
alternating periods of high respiratory frequency and apneas that can produce brief periods of 
hypoxia (Viemari et al., 2005; Stettner et al., 2007). We examined the effects of hypoxia by 
applying 200 µM KCN. The effects of KCN on respiratory neurons in vivo are identical to 
oxygen depletion (Brockhaus et al., 1993). As in the data observed in the functionally intact 
preparation (Mironov and Langohr, 2005), the neurons in organotypic slices responded with an 
initial augmentation of activity, followed by a simultaneously developing depression with a 
calcium increase (Fig. 20).  
After hypoxia [Ca
2+
]i levels slowly returned to control values, taking much more time 
for KO than WT neurons. The decay of depolarisation-induced transients after hypoxia was 
also much slower for KO neurons. Notably, after a pretreatment of slices with BDNF 
(lowermost trace in Fig. 19), the two hypoxia-related parameters of calcium homeostasis were 
practically identical to the WT responses. After a brief application of chemical hypoxia (KCN) 
we also observed the retraction of neuronal processes (Fig. 20A, row 1). The effects developed 
within 1 h and showed a clear correlation with [Ca
2+
]i increase during hypoxia (Fig. 20B). The 
retractions in KO neurons were about twice as frequent as observed in the WT neurons. 
Pretreatment with BDNF produced much smaller effects during subsequent application of 
hypoxia that were in a range observed in WT neurons (Fig. 20A, row 2). The effects of CCCP 
and thapsigargin on the retraction of neurites were similar to those of hypoxia (rows 3 and 4 in 
Fig. 20A). From the viewpoint of calcium buffering this can be explained by an influence of 
the largest contributions to calcium increases by efflux of Ca
2+
 from ER and mitochondria 
which are known to be evoked during hypoxia (Mironov and Langohr, 2005). 
Calcium-induced retraction of neurites was observed only for relatively long lasting (≈1 
min) calcium elevations, while calcium transients elicited by brief depolarisations did not 
produce noticeable changes. Some neurites were retracted after longer lasting transients 
occurring in some neurons without any treatment, interrupting the intrinsic activity (Fig. 21A). 
However, such events were extremely seldom, e. g., in the field of view containing 8-10 
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neurons, only few of these events could be recorded within a 1 h observation time (Fig. 21B). 
These treatment-independent events were more frequently observed in KO neurons (Fig. 21B), 
where they had larger amplitudes (0.64 ± 0.12 µM) and slower rates of decay (21.2 ± 1.2 s). 
After such specific transients the neurites were retracted  the relative decrease in twelve KO 
neurons was 16 ± 5 % and in six WT neurons was 6 ± 3 % (measured 1 h after the transient). 
The differences can be explained by larger amplitudes and durations of spontaneous transients 
in KO neurons (Fig. 21A). 
After brief incubation of KO neurons with BDNF the values of basal calcium changed 
from 0.16 ± 0.02 to 0.08 ± 0.02 μM (means for 6 to 10 single neurons measured in four 
different experiments) and became close to those measured in WT neurons. This can be 
explained using a model developed on the basis of examination of hippocampal and thalamic 
neurons (Mironov, 1994). There are several systems that participate in calcium removal, but 
normally SERCA gives the most significant contribution. [Ca
2+
]i levels are determined by a 
balance between calcium influx and its removal from the cytoplasm. Therefore under 
assumption that the influx of Ca
2+
 is constant, the ratio of removal speed values measured in 
the two different conditions e. g. one calcium removal system is not active or weakly 
expressed, is given by the ratio of calcium levels. The decay times give another estimation of 
removal speeed values. Both approaches give the apparent values of [Ca
2+
]i removal speed in 
WT and KO neurons which differ by a factor of 2. 
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Figure 19. Calcium responses to hypoxia and their modification by BDNF (Mironov et al., 
2009a). 
Chemical hypoxia was induced by KCN (200 μM) and the slow calcium buffering was assessed by 
applying high-K
+ 
before and after this treatment. The time constants of [Ca
2+
]i decay and the rates of 
[Ca
2+
]i recovery after hypoxia are indicated near each trace. Note the prolonged recovery of calcium 
levels after hypoxia in neurons from Mecp2 KO mice that was corrected to WT levels after applying 





Figure 20. Retraction of neuronal processes after global calcium increases. 
 
(A) Images of the respiratory network in wild-type and Mecp2 KO mice at P28 obtained before and 60 
min after application of the agents which produced long-lasting calcium increases – a chemical hypoxia 
(200 μM KCN) in control and after pretreatment with 20 ng/ml BDNF for 20 min, 1 μM thapsigargin 
and 1 μM CCCP. The positions of some retracted processes are indicated by arrowheads. (B) 
Correlations between relative shortening of the processes and measured peak [Ca
2+
]i. Straight lines 
show linear regression of the data (all correlation coefficients are >0.95).  




Figure 21. Spontaneous [Ca
2+
]i increases and retraction of neuronal processes (Mironov et al., 
2009a). 
(A) Selected episodes of spontaneous rhythmic activity interrupted by long-lasting calcium transients. 
(B) Mean amplitudes and frequencies of observation of these transients. (C) The images taken before 




Figure 22. Expression of neuron-specific Epac1-camps (Mironov et al., 2009b). 
(A) Representative original images of AAV-Epac1-camps-transduced organotypic slice which 
contained pre-Bötzinger complex (preBötC) and other characteristic nuclei (XII – Nucleus hypoglossus, 
NTS – Nucleus tractus solitarii, IO – inferior olive, Sp5 - spinal nucleus); (B) Neurons in preBötC. The 
images were acquired at x10 (A) and x40 (B) magnification. To obtain the panoramic view of the whole 
slice in (A), the images with overlapping parts were taken in the same horizontal plane and then 
combined. 
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5.10 Neuron-specific expression of cAMP and calcium dependent 
changes 
Application of AAV-Epac1-camps vector produced sensor expression in many neurons 
in the organotypic brainstem slice (Fig. 22A). The neurons were combined into groups with 
organisation corresponding to the characteristic nuclei in this section of the brainstem 
(Ruangkittisakul et al., 2006). The sensitivity of Epac1-camps to register [cAMP]i changes was 
first examined in tests where the activities of AC and PDE were modulated. Applications of 1 
µM forskolin (a specific AC activator), 50 µM isobutylmethylxanthine (IBMX, non-specific 
PDE inhibitor), 1 µM rolipram (a specific inhibitor of PDE4 (de Boer et al., 1992), and 0.1 mM 
2′5′-dideoxyadenosine (DDA, membrane-permeable AC inhibitor) induced changes in [cAMP]i 
which were in line with the presumed targets of the drugs (Fig. 23). Induced drug-based effects 
were reversible and the responses could be repeatedly elicited after washing them out for 15 
min. Rolipram was the most effective among PDE inhibitors - the increases in [cAMP]i 
induced by PDE3 inhibitor milrinone (1 µM) and PDE2 inhibitor EHNA (10 µM) were 0.58 ± 
0.05 and 0.21 ± 0.06 µM, respectively. These effects were smaller than those induced by 
rolipram, which was in an agreement with their efficacy shown in cardiomyocytes (Nikolaev et 
al., 2006). Specific actions of rolipram in preBötC neurons are in line with its stimulating effect 
on the respiratory motor output (Ruangkittisakul et al., 2006). Activation of metabotropic 
receptors led to delayed [cAMP] increases. The bottom two panels in Fig. 23 show the actions 
of 5-HT and mGluR1/5 agonist (S)-3,5-dihydroxyphenylglycine (DHPG) which are consistent 
with activation of G-protein-coupled receptors for serotonin and glutamate. The data describing 
the kinetics of changes in cAMP levels presented on Table 3. More detailed analysis was not 
performed because the time courses of changes in cAMP concentration can be determined by 
several factors that we here can not correctly estimate. 
cAMP-signalling pathways are often activated by Ca
2+ 
influx (Huang and Kandel, 1998; 
Alberts et al., 2002) via an increase in AC activity and modulation of cAMP-hydrolyzing 
phosphodiesterase (Antoni, 1997; Ang and Antoni, 2002; Cooper, 2003; Hurley, 2006). On the 
contrary cAMP and PKA modulations of Ca
2+






Figure 23. [cAMP]i changes in preBötC neurons after modulation of cAMP-signalling 
pathway (Mironov et al., 2009b). 
Representative responses due to modulation of activity of AC, PDE and activation of metabotropic 
receptors are shown. AC was stimulated with forskolin and inhibited with 2′5′-dideoxyadenosine 
(DDA), PDE was antagonized with IBMX and rolipram, and Group I metabotropic glutamate receptors 
were activated with (S)-3,5-dihydroxyphenylglycine (DHPG). Fluorescence signals were averaged over 
the soma of neurons and transformed into cAMP concentrations as described in Methods. 
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Table 3. Mean [cAMP]i changes observed after modulation of cAMP signaling pathway and 
activation of G-protein coupled glutamate and serotonin receptors (Mironov et al., 2009b).  
Forskolin  
1 µM  
IBMX 









1.62 ± 0.12 1.45 ± 0.07 -0.12 ± 0.05 1.19 ± 0.08 0.74 ± 0.07 0.81 ± 0.05 
Mean data ± S. E. M. were obtained in 4 to 8 neurons in four different preparations and are presented as changes 
from the resting cAMP level (mean = 0.09 ± 0.03 µM). Group I metabotropic glutamate receptors (mGluR1/5) 
were activated with (S)-3,5-dihydroxyphenylglycine (DHPG). 
 
are known to influence Ca
2+
 signal transduction (Nakade et al., 1994; Dean et al., 1997; Bruce 
et al., 2003; Holz et al., 2006). In order to examine possible mechanisms of crosstalk between 
Ca
2+ 
and cAMP, we loaded transduced neurons with fura-2 (Harbeck et al., 2006) and evoked 
[Ca
2+




release from internal stores. The first pattern is similar to the tetanic stimulation which is often 
used in the analysis of neuronal plasticity (Huang and Kandel, 1998). At the peak of [Ca
2+
]i 
transient [cAMP] started to increase and reached its maximum during [Ca
2+
]i recovery to the 
resting value (see Fig. 24A). Induction of calcium release from ER with 1 mM ATP (Mironov, 
1994) also produced delayed [cAMP]i increases with amplitude and duration similar to those 
induced by membrane depolarisation. 
Various isoforms of AC and PDE are known to be differentially activated by Ca
2+ 
(Willoughby and Cooper, 2007). Ca
2+
-dependent stimulation of PDE would decrease [cAMP]I; 
however, our observations show the opposite indicating a dominating role of AC modulation in 
Ca
2+
-dependent increases. After blockade of AC activity with DDA, the amplitude of [Ca
2+
]i 
transients became smaller (Fig. 24B). Thus a decreased production of cAMP promotes 
dephosphorylation of Ca
2+ 
channels and leads to decrease in their activity (Landa et al., 2005). 
Conversely, the [Ca
2+
]i transients showed increased amplitude after blockade of PDE (Fig. 
24C) that points at PKA stimulation and subsequent phosphorylation of the channels (Landa et 
al., 2005). 
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Figure 24. Interrelationships between calcium and cAMP transients measured with fura-2 and 
Epac-1-camps (Mironov et al., 2009b). 
Cytoplasmic calcium and cAMP (grey and black traces, respectively) were recorded with fura-2 and 
Epac-1-camps during testing challenges to 50 mM K
+
 and 1 mM ATP as indicated. The applications 
were made in control (A) and in the presence of 0.1 mM DDA (B) or 50 µM IBMX (C) to inhibit the 
activity of AC and PDE, respectively. Note changes in the amplitude of both calcium and cAMP 
transients after the treatments. The two panels in (D) show [Ca
2+
]i and [cAMP]i changes recorded after 
10 min preincubation with 1 μM thapsigargin to deplete calcium stores (left) and in Ca
2+
-free solution 
(right panel). Values representing mean [Ca
2+
]i and [cAMP]i increases and Ca
2+ 
release in the presence 
of drugs modulating cAMP and Ca
2+ 
homeostasis presented on Table 4 and Table 5, Fig. 25 and Fig. 26. 
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Table 4. Mean [Ca
2+
]i and [cAMP]i increases due to membrane depolarisation and Ca
2+ 
release 
in the presence of drugs modulating cAMP and Ca
2+ 




  Control 
IBMX 










]i 0.44 ± 0.07 0.72 ± 0.08  0.24 ± 0.06 0.31 ± 0.05 0.01 ± 0.01 
τ (s),  
Ca decay 
14.2 ± 1.5 16.4 ± 1.8  14.1 ± 1.4 13.8 ± 1.6 n.s. 
[cAMP]i  1.52 ± 0.09  3.22 ± 0.17 0.25 ± 0.04 0.94 ± 0.08 0.04 ±0.01 
t1/2 (s),  
cAMP rise 
15.6 ± 2.5 19.5 ± 1.9  16.2 ± 2.3 24.2 ± 2.7 
1,2 – n. s, 
2,4 – p < 0.1 
t1/2 (s),  
cAMP decay 
12.2 ± 1.5 n. d. 10.2 ± 1.5 14.1 ± 1.5 n. s. 
Mean data ± S. E. M. were obtained in 4 to 8 neurons in four different preparations. 
 
 
Figure 25. Kinetics of [Ca
2+
]i and [cAMP]i increases due to membrane depolarisation and Ca
2+ 
release in the presence of of drugs modulating cAMP and Ca
2+ 




]I increase (A) and mean Ca decay time (B) due to membrane depolarisation induced by high K
+  
(50 
mM)- Columnes reperesent cellis in control, in presense of IBMX, DDA, and thapsigargin respectively. Violet 
bar, when present, indicates absence of Ca
2+-
. Second row represents mean [cAMP]i increase (C), mean rise (D) 






Table 5. Mean [Ca
2+
]i and [cAMP]i increases due to membrane depolarisation and Ca
2+ 
release 
in the presence of drugs modulating cAMP and Ca
2+ 
homeostasis (Mironov et al., 2009b). 
ATP (1 mM) 
  Control 
IBMX 










]i 0.39 ± 0.07 0.52 ± 0.08 0.22 ± 0.05 0.02 ± 0.01 0.31 ± 0.05 
t1/2 (s),  
Ca rise 
9.2 ± 1.2 8.5 ± 1.0  9.1 ± 1.1 n. d.   
14.1 ± 1.5,  
p < 0.1 
τ (s),  
Ca decay 
22.2 ± 3.1 24.2 ± 2.7  24.4 ± 2.5 n. d.  21.4 ± 1.7 
[cAMP]i  1.44 ± 0.08 2.24 ± 0.07 0.36 ± 0.03 0.04 ± 0.01 1.42 ± 0.08 
t1/2 (s),  
cAMP rise 
42.4 ± 4.5 32.2 ± 3.4  54.2 ± 5.5 
1,3 – n. s. 
2,5 – p< 0.1 
18.6 ± 2.5 
t1/2 (s),  
cAMP decay 
24.2 ± 2.5 n. d. 27.4 ± 3.2 26.4 ±3.1 15.4 ± 2.5 
Here n.s. refers to non-significant differences, n.d. – to non determined. Mean data ± S. E. M. were obtained in 4 
to 8 neurons in four different preparations. 
 
 
Figure 26. Kinetics of [Ca
2+
]i and [cAMP]i increases due to membrane depolarisation and Ca
2+ 
release in the presence of of drugs modulating cAMP and Ca
2+ 




]I increase (A) and mean Ca rise (B) and decay time (C) due to membrane depolarisation induced by 
1 mM ATP. Columnes reperesent cellis in control, in presense of IBMX, DDA, and thapsigargin respectively. 
Violet bar, when present, indicates absence of Ca
2+-
. Second row represents mean [cAMP]i increase (D), mean rise 






 Removal of extracellular Ca
2+
 or introduction of 0.1 mM Cd
2+
, which blocks all 
pathways of Ca
2+
 entry into the cell, abolished the changes in [cAMP]i induced by 
depolarisation. In Ca
2+
-free solution the effects of ATP were still present (the right panel in Fig. 
24D) that excludes the role of Ca
2+
 influx after activation of ionotropic P2X receptors. After 
depletion of ER with Tg the effects caused by membrane depolarisations were reduced (the left 




release (CICR, Fabiato 
and Fabiato, 1979) from the ER via PLC-IP3 signalling pathway amplifies in part cyclic 





-related Epac1-camps responses can potentially report cGMP changes as it was 
recently found in presynaptic boutons of Drosophila neurons (Shakiryanova and Levitan, 
2008), despite the sensor having lower affinity for cGMP (Kd = 11 µM) than that for cAMP 
(Nikolaev et al., 2004). One possible explanation is that in this case the presynaptic calcium 
transients had higher amplitude, inhibited [cAMP] production and made [cGMP] changes 
dominant. Since NO/cGMP signalling pathway plays an important role in preBötC neurons 
(Mironov and Langohr, 2007), we examined whether cGMP changes underlie, at least partially, 
the responses of Epac1-camps. When guanylyl cyclase inhibitor 1H-[1,2,4]-oxadiazolo-[4,3-a]-
quinoxalin-1-one (ODQ, 100 µM), the NOS inhibitor N-monomethyl-L-arginine (L-NMMA), 
and the NO donor S-nitroso-N-acetylpenicillamine (SNAP, 300 µM) were applied, neither 
resting nor stimulus-induced Epac1-camps signals were changed (n ≥ 3 for each treatment). 
Ca
2+
 and cAMP changes showed a considerable crosstalk. When paired stimuli were 
applied, second [Ca
2+
]i increases induced greater effects (Fig. 27A). The enhancement of 
responses can be mediated by Ca
2+
-driven stimulation of PKA with subsequent increase in the 
activity of voltage-sensitive Ca
2+ 
channels (Hoogland et al., 2004). In order to test this 
hypothesis, we applied PKA inhibitor H-89 (N-[2-(p-bromocinnamylamino)ethyl]-5-
isoquinoline
 
sulfonamide hydrochloride, 10 μM for 10 min). Potentiation of secondary [Ca
2+
]i 
and [cAMP]i increases was abolished after pretreatment with H-89 (Fig. 27A). Ca
2+
 release 





Figure 27. Non-linear interactions between Ca
2+
 influx and Ca
2+ 
release in [cAMP] increases 
(Mironov et al., 2009b). 
Testing applications of 50 mM K
+
 and 100 µM ATP were made as indicated by horizontal bars. 
Changes in [Ca
2+
]i and [cAMP]i are shown by grey and black traces, respectively. The experiments were 
done in control (left) and repeated 20 min after pretreatment with PKA inhibitor H-89 (10 µM, right). 
(A) Two depolarisations with high K
+
. (B) A Ca
2+ 
release from ER followed by a depolarisation. (C) 
Depolarisation and Ca
2+ 
release. Note that potentiation of [cAMP] increases during the second 
treatments was abolished by H-89. 
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5.11 Deregulated cAMP homeostasis in Mecp2-/y neurons 
Resting [cAMP]i in living cells is normally slightly below 1 μM (Willoughby and 
Cooper, 2007) and determined by basal activities of adenylate cyclase and phosphodiesterase. 
As described previously (Mironov et al., 2009a), during calibrations we first set a „zero‟ cAMP 
level by inhibiting AC with membrane-permeable inhibitor 2′5′-dideoxyadenosine (DDA, 0.1 
mM) and then applied a specific Epac1-camps activator 8-Bromo-2'-O-methyl-cAMP 
(BrOMecAMP, Kang et al., 2003) in a step-like fashion. A greater decrease of signal by DDA 
in KO neurons is shown in Fig. 28A indicating a lower [cAMP]i level. Subsequent addition of 
BrOMecAMP produced identical increases in WT and KO neurons (Fig. 28B) that excludes 
differences in the expression of the sensor or modification of its properties in the two types of 
cells. 
The resting cAMP was 0.56 ± 0.06 µM in WT and 0.12 ± 0.02 µM in KO neurons; the 
differences were maintained up to postnatal day P35 (Fig. 28C). Brief membrane 
depolarisations imposed by applications of 45 mM KCl for 10 s induced Ca
2+
 influx that 
resulted in slow increase in cAMP levels (Fig. 24). Initially lower [cAMP]i level in KO 
neurons, its smaller increase and faster decay is demonstrated in Fig. 28D. The time-constants 
of decay were 15.6 ± 2.1 and 9.0 ± 1.2 s in WT and KO neurons, respectively (n = 6 for both). 
The responses in WT and KO neurons to activation of AC with forskolin and inhibition 
of PDE4 with rolipram (Yamashita et al., 1997) were distinctly different (Fig. 29). In order to 
interpret the data, we used a simple model of cAMP homeostasis described by the first order 
ordinary differential equation 
dC/dt = α - βC          (4) 
where C is a mean [cAMP]i concentration within the cell, and α and β are the rate constants for 




















Fig. 28. Resting cAMP and its time-dependent changes in preBötC neurons.  
(A) Decreases in 470/535 nm emission ratio (CFP/FRET) after addition of AC inhibitor (100 µM DDA) 
and its increases after application of membrane-permeable Epac activator 8-Bromo-2‟-OMe-cAMP. (B) 
Mean ratios ± S. E. M. were obtained as steady state levels at different concentrations of the agonist and 
normalized to the maximal signal obtained at 30 µM. The data in both animal types were approximated 
by a single Michaelis – Menten-like curve (Kd = 1.5 µM) that coincides with EC50 describing the 
binding of cAMP to Epac1-camps (Mironov et al., 2009a). (C) Resting levels of [cAMP]i in WT and 
KO neurons. Preparations were made at the P3, transduced at P5 and examined at days indicated. (D) 
Representative responses of WT and KO neurons at P14. Brief membrane depolarisation via elevation 
of cytoplasmic calcium (see Mironov et al., 2009a) produced a slow increase in [cAMP] (horizontal 
bar). Notice a lower initial [cAMP]i level in KO neurons, its smaller increase and faster kinetics. 
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The solution of Eq. (1)  










         (5) 
 
predicts that a steady state of level [cAMP]i = α/β is established exponentially according to the 
time constant τ = 1/β. The values of β in WT and KO neurons were 0.063 s
-1
 vs. 0.11 s
-1
, 




. Thus, the rate of basal 
cAMP production is about the same in both cases, whereas cAMP degradation in WT is about 
twice as fast as in KO neurons. [cAMP]i increases induced by forskolin in KO neurons were 
2.1 ± 0.2-fold smaller compared to WT cells (Fig. 29A, n = 6) that can be explained by higher 
values of β in the mutant KO cells. In the presence of forskolin the time-constants of [cAMP]i 
decay were not modified (16.4 ± 2.6 s in WT and 8.1 ± 1.8 s in KO cells). After inhibition of 
PDE4 with rolipram, the increases in cAMP were similar both in WT and KO neurons (Fig. 
29B) and cAMP decay became slower (the time constants were 26.7 ± 3.5 s, WT; and 25.1 ± 
3.8 s, KO). Obtained values correspond to β ≈ 0.04 s
-1 
and represent the rate of [cAMP]i 
degradation by other phosphodiesterases. Subtracting this from the value measured before 
adding rolipram, we obtain for intrinsic activity of PDE4 β’ ≈ 0.02 s
-1
 in WT and β’ ≈ 0.06 s
-1
 
in KO cells, i. e., PDE4 is about three times more active in the KO neurons. We also examined 
BDNF based effects on [cAMP]i homeostasis because previously observed positive influence 
of BDNF on responses in the mouse model of RS (Mironov et al., 2009) can be gated by both 
calcium- and cAMP-dependent processes. After pretreatment with BDNF (20 ng/ml, 30 min), 
the responses to forskolin, rolipram and membrane depolarisation in WT and KO neurons 
became identical (Fig. 29C, D). These effects of BDNF in KO neurons were not observed in 
the presence of 100 nM TrkB blocker K252a (n = 6). Electrical stimulation, a treatment that is 
often used to study neuronal plasticity (Byrne and Kandel, 1996), elicited [cAMP]i responses 
that were similar to those evoked by high-K
+
. The amplitude of the transients increased with 
the number of pulses in a sequence (Fig. 30). They had smaller amplitudes that can be 
explained by smaller calcium increases that caused weaker stimulation of AC. Both forskolin 
and rolipram increased the amplitude of transients, but only rolipram changed their time- 
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Figure 29. [cAMP]i changes induced by forskolin and rolipram and their modulation by BDNF. 
High K
+
 (45 mM) was applied before and after additions of 1 μM forskolin and 1 μM rolipram to 
activate AC and inhibit PDE4, respectively. The responses were measured in the wild-type and KO 
neurons in control (A, B) and after pretreatment of slices with 20 ng/ml BDNF for 30 min (C, D). 
 
 
Figure 30. [cAMP]i changes evoked by electrical stimulation. 
Electric pulses (10 ms, +15 V, interval 1 s) were applied to slices through bath electrodes as shown in 
the uppermost inset. Four rows of traces present the responses obtained in control and in the presence of 
1 µM forskolin, 1 µM rolipram and 20 ng/ml BDNF. Note different amplitudes and time-courses of 




course. WT and KO neurons showed similar differences in kinetics as described above and 
these differences were removed after pretreatment with BDNF (20 ng/ml for 30 min) as the two 
bottom traces in Fig. 30 show. This again indicates a positive role of BDNF on [cAMP]i 
homeostasis that can be attributed to the enhanced activity of PDE4 in KO neurons. The results 
of our studies point to a diminished activity of K-ATP channels in the KO neurons which play 
an important role in their reaction to hypoxia (Mironov et al., 1999a) and intrinsic activity 





 This work is devoted to the investigation of morphological and physiological changes 
during maturation of the inspiratory neurons in the preBötC complex and their functional 
difference with Mecp2 null cells used as a model of Rett Syndrome (RS). Recent findings 
reveal multiple physiological properties of RS, which include 1) modification of synapses 
during the first two weeks of development (Nelson et al., 2006; Chao et al., 2007), 2) impaired 
hippocampal plasticity (Asaka et al., 2006), 3) long-term potentiation (Asaka et al., 2006; 
Moretti et al., 2006), 4) breathing irregularities (Viemari et al., 2005; Stettner et al., 2007), 5) 
increased neuronal vulnerability during excitotoxicity in the cerebellum (Russell et al., 2007), 
and 6) enhanced susceptibility to hypoxia in the hippocampus (Fisher et al., 2008). Molecular 
mechanisms of RS development are still a matter of investigations (Chahrour et al., 2008; Hite 
et al., 2009; Gonzales and LaSalle, 2010), yet some manifestations of these genetic 
disturbances have already been studied with the newly-developed powerful physiology tools. 
It is well known that Ca
2+ 
participates in a wide range of physiological processes of 
signal transduction, neurotransmitter release, and is one of key players in the respiratory 
rhythm generation and neuronal plasticity. Here we investigated whether the origin, rates, and 
kinetic properties of Ca
2+
 release differ in wild-type (WT) and Mecp2 knockout neurons (KO) 
under normal and hypoxic conditions. We hypothesised that disbalance in slow Ca
2+
 buffering 
and cAMP homeostasis may induce certain differences in the morphological organisation and 
mechanism of rhytmogenesis in the preBötC complex. Experiments with the use of 
corresponding mice KO models have recently documented that changes in Mecp2 expression 
levels modify organisation of synapses, neuronal plasticity, and vulnerability, and play 
essential role in the development of breathing disorders in early postnatal life (Chen et al., 
2001; Roloff 2005). Since deficit in Mecp2 expression corresponds to many if not all of the 
clinical signs of RS (Roloff 2005; Ogier and Katz, 2008) we used KO mice as a model for RS. 
6.1 Electrophysiology 
The breathing activity and rhythmogenesis is a complex process that correlates with the 
periodic changes in oxygen consumption (Brockhaus et al., 1993), intracellular calcium (Baker 
et al., 1995; Koshiya and Smith, 1999; Thoby-Brisson et al., 2003; Mironov and Langohr, 
 87 
2005; Potts and Paton, 2006; Ruangkittisakul et al., 2006), mitochondrial properties (Mironov 
et al., 2005a,b), and activity of K-ATP-sensitive channels (Haller et al., 2001). One of the most 
important elements of this system of respiration control and supervision is represented by the 
preBötC (Smith et al., 1991). Although the brainstem contains at least one more oscillator - the 
parafacial respiratory group (pFRG) - it is still under discussion whether the preBötC is the 
primary site of rhythmogenesis at all stages of development or it is overridden with the pFRG 
at birth (Forster, 2006; Onimaru et al., 2006). Nevertheless in normal adult animals the process 
of generating of breathing “rhythm” is normally dominated by preBötC while pFRG is mostly 
involved in providing “drive” (Janczewski et al., 2002; Borday et al., 2004; Janczewski and 
Feldman, 2006). 
A lot of important information on the respiratory rhythmogenesis was delivered from 
electrophysiological studies of single respiratory neurons and from the slices showing rhythmic 
respiration-related activity (Matheison and Maler, 1988; Burnard et al., 1990; Nolan and 
Waldrop, 1993; da Costa and Behbehani, 1995; Martin-Caraballo and Greer, 1999). Our patch-
clamp recordings performed in brainstem slices showed that modulation of K-ATP channel and 
neuronal activities by ATP and BDNF in cerebellum granule and preBötC cells are 
qualitatively similar. Both ATP and BDNF elicited the effects which were similar to those 
observed in the primary culture of preBotC neurons. This substantiates the results of detailed 
investigations of K-ATP channels in culture suggesting common operating mechanisms. The 
only difference between the effects in slices and in culture is the time-course of the responses 
that can be attributed to a slower delivery of the drugs to the bulk of the slice. 
In the patch-clamp studies of Mecp2 null mice the initial activity of K-ATP channels 
was much reduced as manifested by distinctly smaller probability of opening. Activation of 
these channels produces membrane hyperpolarization and enhances stability of the resting state 
(“a decreased vulnerability”, Yamada et al., 2001; Allen and Brown, 2004). Thus Mecp2 -/y 
neurons with their lower levels of channel activity should possess an enhanced excitability as 
compared to the wild-type. Weaker activity of „protective‟ K-ATP channels (Ballanyi, 2004) 
may produce the intrinsic disturbances in calcium and cAMP homeostasis having such 
consequences as improper development of the synapses in Mecp2 -/y neurons as discussed 
below. Notably, after pretreatment with exogenous BDNF the K-ATP channels activity in the 
Mecp2 -/y neurons resembled that observed in the wild-type. Such positive effects of BDNF in 
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both cerebellum and brain stem indicate that disturbances in K-ATP channel activity in Mecp2 
null cells are probably caused by low BDNF levels and this can be compensated at least in 
vitro. This is in line with the recent observations demonstrating that at least some types of 
Mecp2 null and BDNF lacking neurons are more vulnarable than WT cells (Fisher et al., 2008; 
Russell et al., 2007). Moreover, the recent findings reveal physiological properties of MeCP2 
deficient cells, such as modification of synapses during the first two weeks of development 
(Nelson et al., 2006; Chao et al., 2007), impaired hippocampal plasticity (Asaka et al., 2006), 
long-term potentiation (Asaka et al., 2006; Moretti et al., 2006), and breathing irregularities 
(Stettner et al., 2007; Viemari et al., 2005).  
It is worth noting that the results of electrophysiological studies must be treated with 
caution because in some cases KO genotype produces relatively small obvious phenotype 
compared to the one expected from the pharmacological blockade of the channels. Moreover, 
KO cells may compensate through reconfiguration and appropriate tuning of neuronal 
conductance‟s (Marder and Goaillard, 2006). Electrophysiological studies can provide 
information about electrical properties of a single cell, but to understand interaction between 
neurons one should examine at least a representative part of the whole network. This 
challenging task requires changing from electrophysiology to optical imaging. 
 
6.2 Disturbances in network topology and neurite retraction in 
Mecp2 KO mice 
Calcium transients correlate with rhythmogenesis in respiratory neurons (Baker et al., 
1995, Koshiya and Smith 1999, Onimaru et al 2006). At low resolution functionally intact 
slices demonstrate calcium transients in phase with inspiratory bursts (Mironov, 2009). 
Respiratory motor output is generated within the preBötC in the dispersed structures that can be 
associated with the unit predicted by 'group pacemaker' hypothesis (Mironov, 2009). Single-
channel recordings show that inspiratory bursts appear after activation of mGluR1/5 (Mironov, 
2009). Activation of this receptor in turn produces calcium waves that reach soma and activate 
calcium-activated nonselective cation TRPM4 channels (Mironov, 2008). These two types of 
channels are thought to be functionally coupled through dendritic calcium waves generated by 
mGluR at least in cortex (Larkium et al., 2003; Hangenston et al., 2008) and in preBötC 
(Mironov, 2008). Fine structure of networks can be revealed in immunofluorescence studies on 
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fixed cells. In the respiratory kernel, this technique was used to visualize the neurons which 
express NK-1, HT-5, and μ-opioid receptors, proposed to form a population of inspiratory 
neurons (Gray et al., 1999; Guyenet and Wang, 2001; Alheid et al., 2002; Manzke et al., 2003). 
Such high-resolution methods provide important data about the wiring within the networks, but 
say little about the function and do not allow any estimation of physiological condition of the 
cell. 
This problem can be solved by in vivo imaging. However, commercial calcium 
indicators such as fura-2 or fluo-3 stain neurons as well as glia, producing blurred images. We 
used adeno associated virus leading to expression of EGFP under the neuron-specific promoter 
synapsin1 to transduce neurons in the respiratory network, to map them, and to reveal their 
connections. AAV-mediated transduction made the neurons in slice clearly visible and, at the 
same time, the cells transduced with AAV retained rhythmic activity, remained electrically 
excitable and reacted on depolarisation. The images obtained from AAV transduction sharply 
contrast with the blurred pictures of neuronal somata obtained by non-selective staining with 
out-of-focus fluorescence from the glial cells around. These improvements in the imaging of 
neuronal processes allowed us to reveal the details of the fine structure of neuronal organisation 
of preBötz under physiological conditions and gave new unexpected results on the organization 
of the respiratory network. The information obtained from exclusive neuronal staining was 
used to analyse interactions between the neurons that formed small clusters, to reveal their 
structure and connections, and to obtain the wiring diagrams within the network (Mironov, 
2009).  
There is no clear evidence that brains of RS patients and Mecp2 null mice exhibit 
morphological abnormalities (Ogier and Katz, 2008 vs. Kitt and Wilcox, 1995). The 
neurological dysfunction is rather profound during RS and reduction in brain size is postulated 
to be the only morphological change. These changes in morphology can be explained by a 
decrease in neuronal size rather than in the number of cells: for cortex, thalamus, basal ganglia, 
and hippocampus this decrease was shown by Kitt and Wilcox (1995), for dysmorphic 
olfactory neurons by Ronnett et al., 2003. Kitt and Wilcox also reported a decrease in the 
number of neurons in substantia nigra pars compacta (SNpc) as evidence for cell death in RS. 
Our data for the preBötC neurons support this finding rather than a 'no detectable cell loss' 
presented by Ogier and Katz in their recent review (Ogier and Katz, 2008). In our investigation, 
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Mecp2 null neurons of preBötC were of smaller size and had fewer connections. These data 
were in accordance with Larimore and Wenk, who pointed to this effect as a hallmark for RS 
(Larimore et al., 2008, Wenk, 1997). 
The entire respiratory network in neonatal mice was estimated to consist of about 600 
neurons (Feldman and Del Negro, 2006). The morphology of neurons in WT slices as well as 
their organisation did not change significantly within the first two postnatal months, while the 
morphology of neurons and network organisation in KO mice was apparently reorganized 
(Mironov et al., 2009). As we showed, the number of neurons, their processes and connections 
were decreasing in KO slices during this time, while developing in WT. In the case of strictly 
limited number of cells, even a small reduction in connectivity can produce irregularities in 
rhythm generation similar to irregularities generally observed in rhythmogenesis of RS network 
(for more details see Mironov, 2009). Brief hypoxia produced global calcium increase and 
subsequent retraction of some neuronal processes, and could decrease neuronal connectivity in 
the KO slices. If the network functioning becomes unstable, interruptions in breathing produce 
new hypoxic episodes leading to further decreases in neuronal connectivity until no rhythmic 
pattern is generated. Among other symptoms, the RS mouse model B6.129P2(C)-Mecp2
tm1-1Bird 
is characterised by spontaneous interruptions of breathing activity (Viemari et al., 2005; 
Stettner et al., 2007) that increase in severity and frequency. We conclude that the above time-
dependent retraction results in an instability related to the appearance and progression of 
breathing disorders in RS. 
Relevant compensatory mechanisms must be active to counteract these deleterious 
effects during normal development. These mechanisms should include at least one factor 
ubiquitously present in the brain and involved in the development of neuronal network (e.g., 
participating in regulation of survival and growth of neurons during development, or the 
establishment and maintenance of synaptic plasticity). One of the promising candidates is IGF-
1 factor that participates in changes in brain structure development in Mecp2 mutant mice. 
IGF1 is directly involved in development of brain size (Beck et al., 1995) and endogenous 
brain Igf1 expression peaks during postnatal development (Werner et al., 1989; Daftary and 
Gore, 2003). IGF-1 is barely detected in the normal adult murine brain (Andersson et al., 1988; 
Rotwein et al., 1988; Bondy, 1991), and treatment with exogenous IGF-1 significantly 
improves brain reduction in mutant mice (Tropea et al., 2009). Another possible candidate is 
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BDNF: this highly conserved growth factor with widespread functions is ubiquitously present 
in soma as well as in processes of the neurons in the developing brain. BDNF is involved in 
survival, growth of neurons during development, and the establishment and maintenance of 
synaptic plasticity (Bekinschtein et al., 2008). On the other hand, BDNF transcription depends 
on CREB-CREST complexes and thereby involves intracellular Ca
2+ 
stores and voltage-
sensitive calcium channels (VSCC) into processes of regulation and formation of dendritic tree 
(Wong and Ghosh, 2002). We showed that cultivation of KO-neurons in presence of BDNF 
resulted in a normal development of neuronal network and morphology within a slice: the 
neurons were excitable and demonstrated a rhythmic bursting activity. Thus the process of 
brain degradation is at least partially reversed by a treatment with IGF-1 (Beck et al, 1995) and 
BDNF (Mironov et al., 2009) that both participate in early postnatal development of the brain. 
Worth noting that calcium signalling that regulates neurite outgrowth may change during 
development from an IP(3)R-mediated pathway to a RyR-mediated pathway (Arie et al., 2009) 
and may be another starting point for further investigations of the changes in the development 
of Mecp2 null neuronal network. 
Reduction of the brain size is associated not only with the decreased number of cells but 
also with the abnormalities in neuronal branching and maturation. RS affected organisms show 
reduction in dendritic branching of the pyramidal neurons in the frontal, temporal, and motor 
cortices (Armstrong, 2005), shortening of dendritic spines (Belichenko et al., 1994), reduced 
cortical dendritic arborisation (Kishi and Macklis, 2004), delayed neuronal maturation and 
synaptogenesis in the cerebral cortex (Fukuda et al., 2005), and reductions in synapse number 
in the hippocampus (Chao et al., 2007; Ogier and Katz, 2008). In view of our results we 
propose that spontaneous retraction of neuronal processes caused by higher levels of the resting 
calcium can be responsible for the diminished wiring which we observed in maturating 
preBötC of Mecp2 null mice. 
Dynamic process of the dendritic tree formation is characterized by extension and 
retraction of branches, followed by stabilization and growth (Konur and Ghosh, 2005). The 
early development of dendrites is regulated by either molecular signals that control various 
aspects of dendritic development, growth and branching or specific cell-intrinsic programs 
(reviewed in McAllister, 2000, Scott and Luo, 2001, Cline, 2001, Miller and Kaplan, 2003, and 
Jan and Jan, 2003). Semaphorin 3A, which regulates apical dendrite orientation (Polleux et al., 
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2000), neurotrophins, which regulate layer-specific dendritic growth and branching (McAllister 
et al., 1996 and McAllister et al., 1997), Notch1, which restricts dendritic growth (Sestan et al., 
1999; Redmond et al., 2000; Redmond and Ghosh, 2001), Slit-1, which acts as a dendritic 
branching factor (Whitford et al., 2002b), and classical cadherins and their signalling partners 
β-catenins, which play a role in the stabilization of dendrites and spines (Togashi et al., 2002; 
Yu and Malenka, 2003; Abe et al., 2004). Recent observations suggest that most of these 
effects are mediated by calcium signalling (Spitzer et al., 2002; Wong and Ghosh, 2002; 
Henley and Poo, 2004; Hua et al., 2005; McAllister, 2007). 
Transient elevations of intracellular calcium are known to trigger either elongation or 
retraction of neuronal processes in vivo and in vitro. Many regions of the brain, including the 
retina, the hippocampus, and the cortex, show spontaneous calcium transients before the onset 
of sensory experience (Yuste et al., 1995; Feller et al., 1996; Ben-Ari et al., 1997; Garaschuk et 
al., 2000). This period of spontaneous network activity corresponds to a period of rapid 
dendritic growth, and emerging evidence suggests that dendritic growth and branching during 
this period are dependent on calcium signalling. The amplitude, duration, and spatial spread of 
calcium increases determine the resulting effect on the cell: local fast transients facilitate the 
attraction of neuronal processes, whereas the global long-lasting calcium increases promote 
their repulsion (Wong and Ghosh, 2002; Ciccolini et al., 2003; Henley and Poo, 2004; 
McAllister, 2007). For example, dendrites in retina are retracted after thapsigargin-induced 
calcium release from ER (Lohmann et al., 2002). Similar effects were observed in the preBötC 
neurons in response to global calcium increases induced by brief hypoxia and Ca
2+ 
efflux from 
ER and mitochondria. The amount of retraction of neuritis evoked by chemical hypoxia, 
CCCP, and thapsigargin in organotypic slices correlated with the amplitude of the calcium 
transients. 
While much of the study of mechanisms of activity-dependent dendritic development 
has focused on intracellular mechanisms, several observations suggest that neuronal activity 
might also regulate dendritic patterning by regulating the production and release of factors that 
in turn affect dendritic growth. One such mediator is BDNF: its expression is regulated by 
calcium signalling in cortical neurons, and BDNF exerts a major influence on cortical dendrite 
development (Shieh et al., 1998; Tao et al., 1998; Gorski et al., 2003). The effects of BDNF on 
dendritic growth are mediated by MAP kinase and PI3-kinase signalling (Dijkhuizen and 
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Ghosh, 2005). 
Local calcium signalling events have been shown to affect multiple aspects of dendrite 
elaboration including dendrite spine dynamics and formation, initiation of filopodia, and 
dendrite branch stability (Maletic-Savatic et al., 1999; Wu et al., 2001; Wong and Gosh, 2002). 
During development it may also mediate local translational events in response to activity as 
reported for cultured hippocampal neurons (Sutton et al., 2004). In addition to the fast local 
signalling effects of calcium on dendrite structure, neuronal activity initiates a delayed, 
prolonged response on dendrite development. In vitro studies have demonstrated that calcium 
influx can activate a program of signalling that propagates to the neuronal nucleus and 
regulates gene transcription. These nuclear events are crucial because their inhibition prevents 
calcium-induced dendrite growth (Redmond and Ghosh, 2005). 
Calcium levels in neurons are regulated by influx through calcium channels as well as 
by release of calcium from the intracellular stores. Calcium influx is mediated mainly by 
voltage-sensitive calcium channels (VSCC) and NMDA receptors. Release from the stores 
principally involves calcium-induced calcium release (CICR) or activation by ligands that leads 
to the production of IP3, which acts on internal stores. 
Calcium increases converge onto activation of calcium/calmodulin dependent protein 
kinases (CaMK) and the mitogen activated protein kinase (Ras/MAPK) pathway. Two major 
signalling targets of calcium influx are calcium/calmodulin-dependent protein kinases 
(CaMKs) and mitogen-activated kinase (MAPK). Upon calcium entry via VSCC or NMDA 
receptors, calmodulin binds multiple calcium ions and can activate various intracellular 
effectors, including CaMKs (reviewed in Ghosh and Greenberg, 1995). 
Regulation of the dendritic growth by calcium influx via VSCCs appears to involve 
calcium-dependent transcription (Redmond et al., 2002). Calcium-dependent transcription is 
regulated by the calcium-responsive transactivator (CREST), which contributes to the activity-
induced expression of genes controlling dendrite morphology. These genes include the 
candidate plasticity gene-15 (cpg15), Arc, Homer, and Bdnf. Decoding the origin of calcium 
signalling events is coordinated by specification of the transcription of these genes; how the 
proteins encoded by these genes exert specific effects on dendrite morphology is yet to be 
revealed (Redmond and Ghosh, 2005). 
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6.3 Impaired calcium homeostasis in the mouse model of Rett 
syndrome 
Besides regulating of transcription and participation in the dendritic tree formation,  the 
intracellular calcium is a key regulator of up- and downstream processes in neuronal 
development (Mattson et al., 2000). We examined physiological principles underlying 
abnormal development of the respiratory network in RS with use of AAV-based probe with 
inserted coding sequence of the Ca
2+ 
sensor protein D3cpv (Palmer et al., 2006). This probe 
provided us in vivo images with fine details of neuronal processes in neurons of Mecp2 null 
mouse strain B6.129P2(C)-Mecp2
tm1-1Bird
 under physiological conditions. We have found 
specific alterations in calcium homeostasis in preBötC neurons of the Mecp2 null mice. KO 
neurons had higher resting [Ca
2+
]i levels and showed relatively large amplitudes of 
depolarisation-induced calcium transients (Mironov et al., 2009). Decay times in KO neurons 
were also prolonged compared to those of WT neurons thus supporting the hypothesis of 
improper regulation of calcium levels in the KO neurons. Higher levels of resting calcium in 
KO cells could cause a previously observed compromised wiring due to a decrease in the 
number of connections and neurons (Hartelt et al., 2008; Mironov et al., 2009). An imbalance 
in the intracellular calcium regulation in KO neurons might also underlie long-lasting calcium 
transients with large-amplitude after which neuronal processes are retracted. 
Calcium resting values were set up to that typical in WT by the pretreatment of KO 
neurons with BDNF. Experiments with thapsigargin and CCCP point to the fact that the 
intracellular ER store was involved in developing both immediate transient increase with Ca
2+ 
release and subsequent Ca decrease (Mironov et al., 2009). Kinetic properties of long-lasting 
BDNF-dependent Ca
2+ 
release and experiments with tapsigargin and BDNF suggest that BDNF 
most probably stimulates endogenous endoplasmic reticulum Ca ATPase SERCA thus 
decreasing resting Ca
2+ 
level. These data are also supported by the results obtained from the 
cerebellar granule cells pretreated with 10 ng/ml BDNF (Mhyre et al., 2000). 
6.4 Interplay between calcium and cAMP 
Many vitally important processes in neurons are controlled by both cAMP and Ca
2+
 
(Alberts et al., 2002). Fluctuations of [Ca
2+
]i and [cAMP]i in non-excitable cells are often 
interrelated (Borodinsky and Spitzer, 2006) and linked via an increase in an AC activity or 
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through modulation of phosphodiesterases (Antoni, 1997; Hurley, 2006; Cooper, 2003; 
Willoughby and Cooper, 2007). cAMP and PKA - dependent modulations of channels and 
plasma membranes are known in turn to influence Ca
2+ 
signal transduction. (Nakade et al., 
1994; Dean et al., 1997; Holz et al., 1999 ; Bruce et al., 2003). Different isoformes of AC can 
be either stimulated or inhibited by Ca
2+
 (Willoughby and Cooper, 2007). 
Interplay between Ca
2+
 and cAMP involves intermediate mediators and few branching 
steps (Alberts et al., 2002). cAMP activates cAMP-dependent protein kinase PKA, which can 
directly modulate effector proteins by phosphorylation at PKA-specific serine or threonine 
residues or can alter the levels of the effector proteins themselves by modulating gene 
expression. Promoters containing cAMP/Ca
2+
-response elements (CREs) are regulated by the 
transcription factor, CRE-binding protein (CREB) (Mayr and Montminy, 2001; Impey et al., 
2004), which can be activated by extracellular signals that increase the intracellular levels of 
cAMP or Ca
2+
 (Lonze and Ginty, 2002; West et al., 2002; Conkright et al., 2003). cAMP-
dependent regulation of transcription via CREB has been implicated in neurogenesis, cell 
survival, synaptic transmission, and cognitive function in the normal nervous system and may 
be defective in developmental, psychiatric and neurodegenerative disorders (Barco et al., 2002; 
Lonze and Ginty, 2002; Nguyen and Woo, 2003; Carlezon et al., 2005). 
The changes in the [cAMP]i levels in response to the [Ca
2+
]i transients may themselves 
be differentially changed by various downstream targets, e. g., PKA, CREB and Rap to initiate 
events such as gene expression and cell differentiation. PKA-mediated phosphorylation of 
channels is important for normal functioning of the channels and for maintainance of their 
activity mediating Ca
2+ 
entry into the cytoplasm and its release from internal stores. Such 
phosphorylation/dephosphorylation reactions thus close the loop of regulatory feedback 
between Ca
2+ 
and cAMP. Recently cAMP has been shown to activate not only PKA but also 
the guanine exchange factor Epac (de Rooij et al., 1998; Kawasaki et al., 1998). Epac in turn 
activates phospholipase C (PLC) (Schmidt et al., 2001), and could therefore activate PKC 
(Parekh et al., 2000) 
Unfortunately, changes in the intracellular cAMP levels are less described than the ones 
of Ca
2+
, especially those occuring in response to changes in neuronal activity. New observations 
involve applications of cAMP sensors which have been developed in the last decade to different 
neuronal preparations (Adams et al., 1991; Zaccolo et al., 2000; DiPilato et al., 2004; Nikolaev 
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et al., 2004; Ponsioen et al., 2004). Until now such studies have been made only in some cell 
lines (Terrin et al., 2006) and isolated neurons in primary culture (Dunn and Feller, 2008). 
Nevertheless, they reveal the complexity of cAMP dynamics in the cytoplasm. Interactions with 
the neighbouring neurons and the surrounding glial cells and intrinsic electrical activity of the 
neurons both have an important impact on [cAMP]i patterns on different time scales. Ca
2+ 
fluxes 
of different amplitude and time-courses and spontaneous Ca
2+ 
release from the internal stores 
can substantially modulate spatial [cAMP]i . Such changes can underlie different vital cellular 
functions such as neuronal plasticity, differentiation, and development (Kononenko and 
Mironov, 1980; Huang and Kandel, 1998; Ooashi et al., 2000; West et al., 2001; Alberts et al., 
2002; Liu et al., 2003; Hoogland and Saggau, 2004). Although studies of the cAMP dynamics 
are very promising, these investigations were restricted due to the absence of adequate tools for 
in vivo studies. Currently used cAMP sensors are bulky proteins, and the first obstacle in cAMP 
imaging is the delivery of the probe into the cytoplasm. There are several ways to solve this 
problem, each with its own advantages and difficulties. A straightforward way is a single cell 
injection (Adams et al., 1991) though with relatively low output and mechanical stress included. 
Transgenic animals would be an ideal solution and this approach has been successfully used to 
study cAMP signalling in the heart (Nikolaev et al., 2006), pancreatic islets (Kim et al., 2008), 
and the neurons of fruit-flies (Lissandron et al., 2007). Alternative possibility presents a non-
cytotoxic viral gene transfer which application is not limited to a particular animal and tissue 
(Kügler et al., 2003; Teschemacher et al., 2005). We used a strictly neuron-specific promoter 
(Syn1) (Kügler et al., 2003) to deliver cAMP sensor Epac1-camps (Nikolaev et al., 2004) into 
the neurons in organotypic slices. As a proof of this concept, we demonstrated that Epac1-camps 
sensor is expressed in many neurons and reports changes in [cAMP]i levels in μM range after 
various physiological stimuli. We estimated resting cAMP concentrations in WT and KO cells 
and observed that membrane depolarisation and calcium release from the internal stores 
produced [cAMP]i increases that led to a further enhancement of calcium entry or calcium 
release through PKA-dependent phosphorylation. We have also examined some effects of cAMP 
homeostasis in Mecp2 null mice and proved that positive effects of incubation with BDNF can 
be gated by cAMP-dependent processes as well as by Ca
2+. 
After pretreatment with BDNF, KO 
neurons became identical to the WT in their reaction to forskolin, rolipram and membrane 
depolarization while in the absence of BDNF the responses in WT and KO neurons to activation 
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(forskolin) and inhibition (PDE4) of AC were rather different. The WT and KO neurons 
possessed similar rates of the basal cAMP production whereas cAMP degradation in the KO was 
nearly twice as fast as in the WT cells. 
It is a challenging task for future studies to determine how the effects of these two second 
messengers are orchestrated, and how they influence the neuronal activity. We believe that the 
neuronal specificity, optical stability, and sensitivity of Epac1-camp based sensor provide a solid 
platform for further examinations of Ca
2+
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